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Hydroxy-2-styrylchromones 5a−i were prepared by de-
benzylation of benzyloxy-2-styrylchromones 3a−i, which
were synthesised by the Baker−Venkataraman method. The
last step of this method, the cyclodehydration 5-aryl-3-hy-
droxy-1-(2-hydroxyaryl)-2,4-pentadien-1-ones 2a−i, was car-
ried out with a catalytic amount of iodine, or p-toluenesul-
fonic acid, in DMSO. Benzyloxy-3-cinnamoyl-2-styrylchro-
Introduction
Chromones (1-benzopyran-4-ones) are one of the most
abundant classes of naturally occurring oxygen-
heterocycles.[13] The significance of these compounds is
due not only to the important biological functions they play
in Nature, but also because certain derivatives have shown
considerable pharmacological, biocidal, and antioxidant
activities;[2,410] some of them are being marketed as
drugs.[11] 2-Phenylchromones, also known as flavones, are
the major constituents of this class of compounds and have
a wide range of biological activities.[410] Other groups of
chromones, which are less widely-occurring in nature, have
also shown important biological activities. For example, for
the newly-discovered group of 2-styrylchromones, only two
natural derivatives have been found, but they have shown
potent in vitro cytotoxicity against human leukaemia
cells.[12] Prior to the isolation of these natural 2-styrylchro-
mones, studies had already been carried out on numerous
synthetic derivatives,[13] which also showed promising anti-
tumour and anti-allergic activities.[14] More recently, it has
been demonstrated that certain synthetic derivatives are in-
hibitors of the replication of both 1B and 14 serotypes of
the human anti-rhinovirus,[15] while we have found that 3-
allyl-5,7,4-trimethoxy-2-styrylchromone uncouples oxidat-
ive phosphorylation,[16] and that some hydroxy-2-styryl-
chromones act as potent xanthine oxidase inhibitors.[17]
The mechanism of action of polyphenolic compounds as
antioxidants can include the suppression of the formation
of reactive oxygen species, either by the inhibition of en-
zymes (e.g. xanthine oxidase and proteine kinase C) or the
chelation of trace metal ions (e.g. Fe2 or Cu) involved
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mones 4a−f were obtained as by-products in both proced-
ures, but the latter procedure gave benzyloxy-2-
styrylchromones 3a−i in better yields. The structures of all
new compounds were established by extensive NMR studies.
in free radical production. Alternatively, they may act by
scavenging reactive oxygen species (e.g. superoxide anion,
peroxyl, alkoxyl, hydroxyl, and nitric oxide radicals and sin-
glet oxygen), or protecting antioxidant defences. Flavones
have been identified as fulfilling most of the necessary cri-
teria, since several structure-activity studies have shown
that the structural requirements for a strong antioxidant ac-
tivity are a C2C3 double bond conjugated to a carbonyl
group at C-4, a ortho-dihydroxy substitution on ring B (a
catechol moiety) and free OH groups at the C-3 and C-
5 positions.[5,7,9,18]
Taking into consideration the important biological activi-
ties of flavones, namely, their antioxidant activity and their
similarity to 2-styrylchromones, we decided to devote some
attention to the synthesis of hydroxy-2-styrylchromones.
The diversity of the substitution pattern, including the pres-
ence of hydroxyl substituents at certain positions of the
skeleton (5, 7, 3, and 4) and the inherent C-4 carbonyl
group and C2C3 double bond, was taken into consider-
ation, having in mind that further antioxidant structure-
activity studies would be carried out. Following our experi-
ence in the synthesis of 2-styrylchromones,[19] we report
here the synthesis of several new hydroxy- or polyhydroxy-




Benzyloxy-2-styrylchromones 3ai were prepared in
good overall yields according to the three-step sequence
shown in Scheme 1.[20] For this purpose, benzyloxy-2-
cinnamoyloxyacetophenones 1 were obtained from the re-
action of the 2-hydroxyacetophenone derivatives with the
appropriate cinnamoyl chloride, commercially available in
the cases of 1ac, or prepared in situ from the cinnamic
acids and phosphoryl chloride for 1di. The
BakerVenkataraman rearrangement of compounds 1ai
into 5-aryl-3-hydroxy-1-(2-hydroxyaryl)-2,4-pentadien-1-
ones 2ai was carried out by their treatment with an excess
of potassium hydroxide (powder) in DMSO. Cyclodehy-
dration of ketone 2a with a mixture of DMSO and a cata-
lytic amount of iodine, at 90 °C[21] led to the desired 7-
benzyloxy-2-styrylchromone 3a in good yield (74 %). How-
ever, treatment of the intermediate 2b under the same reac-
tion conditions led to the formation of 5-benzyloxy-3-cin-
namoyl-2-styrylchromone 4b (9 %) and the starting mate-
rial 2-benzyloxy-6-hydroxyacetophenone (65 %), but the
expected 5-benzyloxy-2-styrylchromone 3b was not ob-
tained. A plausible mechanism for the formation of these
two compounds is depicted in Scheme 2. In the reaction
medium, the structures involved in the keto-enol equilib-
rium may give rise to compound 6b by reaction with
DMSO.[22] This compound can then react with 2b, leading
to the dimer 7b. A retro-aldol-type reaction of 7b could
then give the starting 2-benzyloxy-6-hydroxyaceto-
phenone and the triketo derivative 8b, which could then
cyclodehydrate to give the 5-benzyloxy-3-cinnamoyl-2-styr-
ylchromone 4b. Since we didn’t use dry DMSO, compounds
6 could also react with water at their enolic carbon, and
Scheme 1
this could be followed by a retro-aldol-type reaction leading
to the 2-hydroxyacetophenone starting materials and the
cinnamic acid-derivatives. This last proposal may explain
the formation of such a large amount of the 2-benzyloxy-
6-hydroxyacetophenone starting material.
Scheme 2
Cyclodehydration of ketones 2ci under the same reac-
tion conditions (i.e. a mixture of DMSO and a catalytic
amount of iodine at 90 °C) led to the desired 2-styryl-
chromones 3ci in poor yields, contaminated in several
cases by the corresponding 3-cinnamoyl-2-styrylchromones
4cf and the starting 2-hydroxyacetophenones. The
amount of the latter compounds was higher when the yields
of 2-styrylchromone derivatives 3ci and 4ci were low.
Since the yields we obtained of 3ci were not acceptable,
we tried the cyclodehydration of ketones 2ai with p-tolu-
enesulfonic acid in DMSO, at 90 °C.[23] In general, the de-
sired benzyloxy-2-styrylchromones 3ai were obtained in
better yields, but the by-products 3-cinnamoyl-2-styrylchro-
mones 4a,c were also obtained in some cases. These results
seem to indicate that the cyclodehydration of 2ai is
favourable in the acidic medium.
Debenzylation of benzyloxy-2-styrylchromones 3ai was
achieved by their treatment with a solution of hydrogen
bromide in acetic acid at reflux, to give the corresponding
hydroxy-2-styrylchromones 5ai in moderate yields.
NMR Spectroscopy
The most noticeable features of the 1H and 13C NMR
spectra of 2-cinnamoyloxyacetophenones 1ai are: i) the
resonances of the 2-CH3 proton and carbon atoms, which
appear at δ  2.472.53 and 29.532.0 ppm, respectively;
ii) the resonances of the benzylic methylenic proton and
carbon atoms, which appear at δ  4.935.21 and
70.071.2 ppm, respectively; iii) the pair of doublets corre-
sponding to the resonances of the Hα (δ  6.376.69 ppm)
and Hβ (δ  7.717.91 ppm) protons; the corresponding
coupling constant, JHα-Hβ  16 Hz, indicates the presence
of a trans configuration of this double bond; iv) the ester
and ketone carbonyl groups’ resonances, which appear at
δ  165.0165.4 and 195.6200.7 ppm, respectively. It is
important to notice that the resonance of the ketone car-
bonyl group of 4-benzyloxy-2-cinnamoyloxyaceto-
phenones 1a,d,g appears at δ  195.6195.8 ppm while
those also bearing a 6-benzyloxy group 1b,c,e,f,h,i appear
at δ  200.5200.7 ppm. This deshielding effect is due to
the lack of conjugation between this carbonyl group and
the aryl ring of the acetophenone, caused by the steric clash
between the two ortho-substituents and the acetyl group.
In the 1H NMR spectra of each one of 5-aryl-3-hydroxy-
1-(2-hydroxyaryl)-2,4-pentadien-1-ones 2ai, there are two
signals, at δ  12.6813.73 and 14.4614.77 ppm, which
are due to protons involved in hydrogen bonding. One can
conclude that these compounds 2ai exist in their enolic
forms, as shown in Scheme 1, with the former signals corre-
sponding to the resonances of the phenolic protons, and the
latter ones being due to the 3-OH protons. The resonance
of 3-OH appears, in most cases, as a doublet, due to the
long-range coupling with 4-H (JH4-3OH  0.61.2 Hz).
From the values of the vicinal coupling constants (3J4H-
5H  16 Hz), it was possible to establish the trans configura-
tion of these two protons.
An important feature of the 1H NMR spectra of 2-styr-
ylchromones 3ai and 5ai is the singlet at δ 
6.136.47 ppm, corresponding to the resonances of 3-H;
this resonance is absent in the spectra of the 3-cinnamoyl-
2-styrylchromones 4af. The analysis of the 13C NMR
spectra of compounds 3ai and 5ai revealed the reson-
ance of C-3 at δ  106.8112.2 ppm, while in the cases of
4af it appeared at δ  122.2123.7 ppm. This deshielding
effect is due to the presence of 3-cinnamoyl substituents in
the cases of chromones 4af. In the spectra of all these
chromones 3ai, 4af and 5ai, the resonances assigned
to β-Η (δ  7.367.74 ppm) and C-β (δ 
136.1139.1 ppm) appeared at higher frequency values
than that of α-Η (δ  6.507.18 ppm) and C-α (δ 
115.5120.7 ppm), due to the mesomeric deshielding effect
of the carbonyl group. In the NMR spectra of compounds
4af, one can also observe the resonances of the other vi-
nylic moiety, α-H (δ  7.117.26 ppm), β-H (δ 
7.587.69 ppm), C-α (δ  125.8128.0 ppm), and C-β
(δ  144.1144.2 ppm). The coupling constant values,
3JHα-Hβ  16 Hz, of all the chromones we synthesised 3ai,
4af and 5ai and also 3JHα-Hβ  16 Hz for 4ai, indi-
cate a trans-configuration of these CαCβ and CαCβ
double bonds.
The assignments of each AB spin-system, corresponding
to the resonances of α-Η/β-Η and α-H/β-H of chromones
4ai, was made on the basis of the connectivities found in
the HMBC spectra. The resonance assigned to β˜-Η corre-
lates with the signals of C-2, C-6, and C-2, whereas that
ascribed to β-H correlates with C-2, C-6, and CO of
the cinnamoyl group (Figure 1).
Figure 1. Main connectivities found in the HMBC spectra of com-
pounds 2ai and 4ai
The 1H NMR spectra of hydroxy-2-styrylchromones
5ai revealed the presence of hydroxyl proton resonances
at δ  10 ppm, assigned to 7,3,4-OH groups, and at δ 
13 ppm, attributed to the 5-OH group. The higher fre-
quency value of the latter is due to the intramolecular hy-
drogen bond of the 5-hydroxy group to the carbonyl group.
The assignments of the carbon resonances of all com-
pounds 1ai, 2ai, 3ai, 4af, and 5ai were made by
analysis of their HSQC and HMBC spectra. Figure 1 shows
some of the main long-range connectivities found in the
HMBC spectra of 5-aryl-3-hydroxy-1-(2-hydroxyaryl)-2,4-
pentadien-1-ones 2ai.
Conclusion
We have prepared several hydroxy-2-styrylchromones
5ai by acidic debenzylation of the corresponding benzyl-
oxy-2-styrylchromones 3ai, which were synthesised by the
BakerVenkataraman method. The cyclodehydration reac-
tion of the intermediates 5-aryl-3-hydroxy-1-(2-hydroxy-
aryl)-2,4-pentadien-1-ones 2ai to give the corresponding
benzyloxy-2-styrylchromones 3ai was studied. Better re-
sults were obtained when the cyclodehydration was carried
out with p-toluenesulfonic acid in DMSO than with a cata-
lytic amount of iodine in DMSO. In both procedures,
benzyloxy-3-cinnamoyl-2-styrylchromones 4af were ob-
tained as by-products.
Experimental Section
General Remarks: Melting points were measured in a Reichert
Thermovar apparatus fitted with a microscope and are uncor-
rected. NMR spectra were recorded on a Bruker DRX 300 spec-
trometer (300.13 for 1H and 75.47 MHz for 13C), with CDCl3 as
solvent, unless otherwise stated. Chemical shifts (δ) are reported in
ppm, and coupling constants (J) in Hz. The internal standard was
TMS. Unequivocal 13C assignments were made with the aid of 2D
gHSQC and gHMBC (delays for one bond and long-range J C/H
couplings were optimised for 145 and 7 Hz, respectively) experi-
ments. Electron impact (EI, 70 eV) MS were recorded on VG Auto-
spec Q and M spectrometers. Elemental Analyses were obtained
with a CHNS 932 Leco analyser (University of Aveiro). Preparative
thin-layer chromatography was performed with Merck silica gel 60
DGF254. Column chromatography was performed with Merck sil-
ica gel 60, 70230 mesh. All other chemicals and solvents used
were obtained from commercial sources and used as received or
dried using standard procedures.
Synthesis of 2-(Cinnamoyloxy)acetophenones 1ai. Method 1: Cin-
namoyl chloride (1.9 g, 11.4 mmol) was added to a solution of the
appropriate acetophenone (5.7 mmol) in dry pyridine (150 mL).
The solution was stirred under nitrogen at room temperature for
12 hours. After that period, the solution was poured into ice and
water (100 mL), and the pH adjusted to 4 with dilute hydrochloric
acid. The mixture was extracted with chloroform (2  100 mL),
and the organic layer washed with water. The solvent was evapo-
rated to dryness, and the residue was purified by silica gel column
chromatography using a (3:7) mixture of light petroleum:dichloro-
methane as eluent. The solvent was evaporated to dryness in each
case, and the residue was crystallised from ethanol to give the ex-
pected 2-cinnamoyloxyacetophenones 1ac.
4-Benzyloxy-2-(cinnamoyloxy)acetophenone (1a): Yield 84.9 %
(1.80 g). M.p. 118119 °C (recrystallised from ethanol). 1H NMR:
δ  2.53 (s, 3 H, 2-CH3), 5.12 (s, 2 H, 4-OCH2C6H5,), 6.69 (d,
J  16.0 Hz, 1 H, α-H), 6.78 (br. s, 1 H, 3-H), 6.92 (dd, J  8.8,
2.4 Hz, 1 H, 5-H), 7.357.44 (m, 8 H, 3,4,5-H and 2,3,4,5,6-
H of 4-OCH2C6H5), 7.61 (dd, J  6.5, 2.1 Hz, 2 H, 2,6-H),
7.88 (d, J  8.8 Hz, 1 H, 6-H), 7.91 (d, J  16.0 Hz, 1 H, β-H)
ppm. 13C NMR: δ  29.5 (C-2), 70.4 (4-OCH2C6H5), 110.0 (C-
3), 112.5 (C-5), 116.8 (C-α), 123.8 (C-1), 127.5 (C-2,6 of 4-
OCH2C6H5), 128.3 (C-4 of 4-OCH2C6H5), 128.4 (C-2,6), 128.7
(C-3,5 of 4-OCH2C6H5), 128.9 (C-3,5), 130.8 (C-4), 132.3 (C-
6), 134.0 (C-1), 135.7 (C-1 of 4-OCH2C6H5), 147.3 (C-β), 151.3
(C-2), 162.8 (C-4), 165.1 (CO), 195.8 (C-1) ppm. EI-MS: m/z
(rel. int.)  372 (8) [M·], 281 (2), 242 (1), 239 (2), 192 (1), 181 (2),
131 (100), 103 (32), 91 (43). C24H20O4 (372.4): calcd. C 77.40, H
5.41; found C 77.48, H 5.51.
6-Benzyloxy-2-(cinnamoyloxy)acetophenone (1b): Yield 85.4 %
(1.81 g). M.p. 9093 °C (recrystallised from ethanol). 1H NMR:
δ  2.53 (s, 3 H, 2-CH3), 5.11 (s, 2 H, 6-OCH2C6H5), 6.58 (d, J 
16.0 Hz, 1 H, α-H), 6.82 (d, J  8.2 Hz, 1 H, 3-H), 6.89 (d, J 
8.2 Hz, 1 H, 5-H), 7.317.42 (m, 9 H, 4-H, 3,4,5-H and
2,3,4,5,6-H of 6-OCH2C6H5), 7.547.57 (m, 2 H, 2,6-H), 7.83
(d, J  16.0 Hz, 1 H, β-H) ppm. 13C NMR: δ  31.7 (C-2), 70.8
(6-OCH2C6H5), 109.9 (C-5), 115.4 (C-3), 116.5 (C-α), 124.9 (C-
1), 127.2 (C-2,6 of 6-OCH2C6H5), 128.1 (C-4 of 6-OCH2C6H5),
128.3 (C-2,6), 128.6 (C-3,5 of 6-OCH2C6H5), 129.1 (C-3,5),
130.7 (C-4), 130.9 (C-4), 133.9 (C-1), 136.0 (C-1 of 6-
OCH2C6H5), 147.1 (C-β), 147.6 (C-2), 156.4 (C-6), 165.0 (CO),
200.6 (C-1) ppm. EI-MS: m/z (rel. int.)  372 (2) [M·], 281 (2),
267 (1), 241 (10), 224 (12), 191 (3), 131 (100), 103 (32), 91 (55).
C24H20O4 (372.4): calcd. C 77.40, H 5.41; found C 77.31, H 5.49.
4,6-Dibenzyloxy-2-(cinnamoyloxy)acetophenone (1c): Yield
95.1 % (2.59 g). M.p. 104105 °C (recrystallised from ethanol). 1H
NMR: δ  2.49 (s, 3 H, 2-CH3), 5.04 and 5.08 (2s, 4 H, 4,6-
OCH2C6H5), 6.42 (d, J  2.2 Hz, 1 H, 3-H), 6.53 (d, J  2.2 Hz,
1 H, 5-H), 6.59 (d, J  16.0 Hz, 1 H, α-H), 7.357.42 (m, 8 H,
3,4,5-H and 2,3,4,5,6-H of 4,6-OCH2C6H5), 7.567.59 (m,
2 H, 2,6-H), 7.84 (d, J  16.0 Hz, 1 H, β-H) ppm. 13C NMR:
δ  32.0 (C-2), 70.4 and 70.9 (4,6-OCH2C6H5), 98.4 (C-5), 101.2
(C-3), 116.7 (C-α), 117.9 (C-1), 127.4 and 127.6 (C-2,6 of 4,6-
OCH2C6H5), 128.3 and 128.3 (C-4 of 4,6-OCH2C6H5), 128.4 (C-
2,6), 128.7 and 128.9 (C-3,5 of 4,6-OCH2C6H5), 130.7 (C-
3,4,5), 134.0 (C-1), 135.8 and 135.9 (C-1 of 4,6-
OCH2C6H5), 147.2 (C-β), 149.5 (C-2), 158.1 (C-6), 161.2 (C-4),
165.2 (CO), 199.5 (C-1) ppm. EI-MS: m/z (rel. int.)  478 (4)
[M·], 435 (2), 387 (6), 373 (1), 347 (9), 345 (15), 330 (4), 181 (2),
131 (100), 103 (20), 91 (53). C31H26O5 (478.5): calcd. C 77.81, H
5.48; found C 77.94, H 5.42.
Method 2: The appropriate cinnamic acid (9.5 mmol) and phos-
phorus oxychloride (4.0 mL, 43.0 mmol) were added to a solution
of the appropriate acetophenone (8.6 mmol) in dry pyridine
(170 mL). The solution was stirred under different conditions of
time and temperature according to the substitution of the com-
pound: 1d and 1e, 60 °C, 24 h; 1f, room temperature, 24 h; 1g and
1h, 60 °C, 4 h; 1i, room temperature, 1 h. After that, the solution
was poured into ice and water (100 mL), and the pH adjusted to 4
with hydrochloric acid. The mixture was extracted with chloroform
(100 mL), and the organic layer washed with water. The solvent
was evaporated, and the residue was purified by silica gel column
chromatography using a mixture of light petroleum:dichlorome-
thane (3:7) as eluent. The solvent was evaporated to dryness in
each case, and the residue was crystallised from ethanol to give the
expected cinnamoyloxyacetophenones 1di.
4-Benzyloxy-2-(4-benzyloxycinnamoyloxy)acetophenone (1d):
Yield 86.1 % (3.54 g). M.p. 197200 °C (recrystallised from etha-
nol). 1H NMR: δ  2.52 (s, 3 H, 2-CH3), 5.11 and 5.12 (2s, 4 H,
4,4-OCH2C6H5), 6.55 (d, J  16.0 Hz, 1 H, α-H), 6.77 (d, J 
2.4 Hz, 1 H, 3-H), 6.91 (dd, J  8.8, 2.4 Hz, 1 H, 5-H), 7.01 (d,
J  8.7 Hz, 2 H, 3,5-H), 7.357.46 (m, 10 H, 2,3,4,5,6-H of
4,4-OCH2C6H5), 7.55 (d, J  8.7 Hz, 2 H, 2,6-H), 7.86 (d,
J  8.8 Hz, 1 H, 6-H), 7.87 (d, J  16.0 Hz, 1 H, β-H) ppm. 13C
NMR: δ  29.7 (C-2), 70.1 (4,4-OCH2C6H5), 109.9 (C-3), 112.5
(C-5), 114.3 (C-α), 115.3 (C-3,5), 123.9 (C-1), 127.0 (C-1),
127.5 and 127.6 (C-2,6 of 4,4-OCH2C6H5), 128.2 and 128.3 (C-
4 of 4,4-OCH2C6H5), 128.7 and 128.7 (C-3,5 of 4,4-
OCH2C6H5), 130.2 (C-2,6), 132.2 (C-6), 135.8 and 136.3 (C-1
of 4,4-OCH2C6H5), 147.0 (C-β), 151.5 (C-2), 161.0 (C-4),
162.8 (C-4), 165.4 (CO), 195.9 (C-1) ppm. EI-MS: m/z (rel.
int.)  478 (0.2) [M·], 372 (0.3), 281 (0.4), 267 (0.2), 254 (12), 237
(11), 224 (2), 131 (31), 103 (7), 91 (100). C31H26O5 (478.5): calcd.
C 77.81, H 5.48; found C 77.72, H 5.51.
6-Benzyloxy-2-(4-benzyloxycinnamoyloxy)acetophenone (1e):
Yield 88.1 % (3.62 g). M.p. 133134 °C (recrystallised from etha-
nol). 1H NMR: δ  2.52 (s, 3 H, 2-CH3), 5.11 (s, 2 H, 4-
OCH2C6H5), 5.13 (s, 2 H, 6-OCH2C6H5), 6.44 (d, J  15.9 Hz, 1
H, α-H), 6.81 (d, J  8.2 Hz, 1 H, 3-H), 6.89 (d, J  8.2 Hz, 1 H,
5-H), 6.99 (d, J  8.7 Hz, 2 H, 3,5-H), 7.327.45 (m, 11 H,
4-H and 2,3,4,5,6-H of 6,4-OCH2C6H5), 7.52 (d, J  8.7 Hz, 2
H, 2,6-H), 7.79 (d, J  15.9 Hz, 1 H, β-H) ppm. 13C NMR: δ 
31.8 (C-2), 70.1 (4-OCH2C6H5), 70.8 (6-OCH2C6H5), 109.9 (C-
5), 114.1 (C-α), 115.2 (C-3,5), 115.5 (C-3), 125.0 (C-1), 127.0
(C-1), 127.3 and 127.5 (C-2,6 of 6,4-OCH2C6H5), 128.2 (C-4 of
6,4-OCH2C6H5), 128.6 (C-3,5 of 6,4-OCH2C6H5), 130.2 (C-
2,6), 130.8 (C-4), 136.0 and 136.3 (C-1 of 6,4-OCH2C6H5),
146.8 (C-β), 147.8 (C-2), 156.4 (C-6), 160.9 (C-4), 165.4 (CO),
200.7 (C-1) ppm. EI-MS: m/z (rel. int.)  478 (7) [M·], 435 (0.5),
387 (0.5), 345 (0.5), 298 (0.5), 254 (0.5), 237 (86), 146 (5), 91 (100).
C31H26O5 (478.5): calcd. C 77.81, H 5.48; found C 77.80, H 5.52.
4,6-Dibenzyloxy-2-(4-benzyloxycinnamoyloxy)acetophenone (1f):
Yield 89.0 % (4.47 g). M.p. 129130 °C (recrystallised from etha-
nol). 1H NMR: δ  2.49 (s, 3 H, 2-CH3), 5.04, 5.08, and 5.11 (3s,
6 H, 4,6,4-OCH2C6H5), 6.42 (d, J  2.1 Hz, 1 H, 3-H), 6.44
(d, J  16.0 Hz, 1 H, α-H), 6.52 (d, J  2.1 Hz, 1 H, 5-H), 6.99
(d, J  8.9 Hz, 2 H, 3,5-H), 7.347.46 (m, 15 H, 2,3,4,5,6-H of
4,6,4-OCH2C6H5), 7.52 (d, J  8.9 Hz, 2 H, 2,6-H), 7.79 (d,
J  16.0 Hz, 1 H, β-H) ppm. 13C NMR: δ  32.0 (C-2), 70.0, 70.4,
and 70.9 (4,6,4-OCH2C6H5), 98.3 (C-5), 101.2 (C-3), 114.2 (C-
α), 115.2 (C-3,5), 118.0 (C-1), 127.0 (C-1), 127.4, 127.5, and
127.6 (C-2,6 of 4,6,4-OCH2C6H5), 128.2 and 128.3 (C-4 of
4,6,4-OCH2C6H5), 128.7 (C-3,5 of 4,6,4-OCH2C6H5), 130.2
(C-2,6), 135.8, 135.9, and 136.3 (C-1 of 4,6,4-OCH2C6H5),
146.8 (C-β), 149.5 (C-2), 158.0 (C-6), 160.1 (C-4), 161.1 (C-4),
165.4 (CO), 199.6 (C-1) ppm. EI-MS: m/z (rel. int.)  584 (2)
[M·], 541 (3), 493 (2), 451 (2), 400 (1), 348 (2), 345 (3), 257 (1),
237 (63), 181 (2), 147 (3), 91 (100). C38H32O6 (584.7): calcd. C
78.06, H 5.52; found C 78.13, H 5.49.
4-Benzyloxy-2-(3,4-dibenzyloxycinnamoyloxy)acetophenone (1g):
Yield 84.0 % (4.22 g). M.p. 127128 °C (recrystallised from etha-
nol). 1H NMR: δ  2.51 (s, 3 H, 2-CH3), 5.09 (s, 2 H, 4-
OCH2C6H5), 5.19 and 5.21 (2s, 4 H, 3,4-OCH2C6H5), 6.47 (d,
J  15.9 Hz, 1 H, α-H), 6.76 (d, J  2.2 Hz, 1 H, 3-H), 6.90 (dd,
J  8.7, 2.2 Hz, 1 H, 5-H), 6.93 (d, J  8.2 Hz, 1 H, 5-H), 7.13
(dd, J  8.2, 1.8 Hz, 1 H, 6-H), 7.19 (d, J  1.8 Hz, 1 H, 2-H),
7.247.48 (m, 15 H, 2,3,4,5,6-H of 4,3,4-OCH2C6H5), 7.78 (d,
J  15.9 Hz, 1 H, β-H), 7.86 (d, J  8.7 Hz, 1 H, 6-H) ppm. 13C
NMR: δ  29.6 (C-2), 70.3 (4-OCH2C6H5), 70.8 and 71.2 (3,4-
OCH2C6H5), 109.9 (C-3), 112.4 (C-5), 113.7 (C-2), 114.0 (C-
5), 114.5 (C-α), 123.5 (C-6), 123.8 (C-1), 127.1 and 127.2 (C-
2,6 of 4,6,4-OCH2C6H5), 127.3 (C-1), 127.5, 127.9, and 128.3
(C-4 of 4,6,4-OCH2C6H5), 128.5 and 128.6 (C-3,5 of 4,6,4-
OCH2C6H5), 132.2 (C-6), 135.7 (C-1 of 4-OCH2C6H5), 136.5 and
136.7 (C-1 of 3,4-OCH2C6H5), 147.1 (C-β), 148.8 (C-3), 151.4
(C-2,4), 162.7 (C-4), 165.3 (CO), 195.9 (C-1) ppm. EI-MS: m/
z (rel. int.)  584 (4) [M·], 360 (2), 343 (31), 251 (3), 242 (9), 181
(11), 131 (3), 106 (11), 91 (100). C38H32O6 (584.7): calcd. C 78.06,
H 5.52; found C 77.94, H 5.64.
6-Benzyloxy-2-(3,4-dibenzyloxycinnamoyloxy)acetophenone (1h):
Yield 69.1 % (3.47 g). Yellow oil. 1H NMR: δ  2.51 (s, 3 H, 2-
CH3), 5.05 (s, 2 H, 6-OCH2C6H5), 5.14 (s, 4 H, 3,4-
OCH2C6H5), 6.37 (d, J  15.9 Hz, 1 H, α-H), 6.78 (d, J  8.2 Hz,
1 H, 3-H), 6.83 (d, J  8.2 Hz, 1 H, 5-H), 6.89 (d, J  8.4 Hz, 1
H, 5-H), 7.06 (dd, J  8.4, 1.8 Hz, 1 H, 6-H), 7.14 (d, J 
1.8 Hz, 1 H, 2-H), 7.267.46 (m, 16 H, 4-H and 2,3,4,5,6-H of
6,3,4-OCH2C6H5), 7.71 (d, J  15.9 Hz, 1 H, β-H) ppm. 13C
NMR: δ  31.6 (C-2), 70.6 (6-OCH2C6H5), 71.0 (3,4-
OCH2C6H5), 109.8 (C-5), 113.5 (C-2), 113.8 (C-5), 114.2 (C-α),
115.3 (C-3), 123.3 (C-6), 124.8 (C-1), 127.0 and 127.1 (C-2,6
of 6,3,4-OCH2C6H5), 127.2 (C-1), 127.8 and 128.0 (C-4 of
6,3,4-OCH2C6H5), 128.4 and 128.5 (C-3,5, of 6,3,4-
OCH2C6H5), 130.7 (C-4), 135.9 (C-1 of 6-OCH2C6H5), 136.5 and
136.6 (C-1 of 3,4-OCH2C6H5), 146.8 (C-β), 147.6 (C-2), 148.7
(C-3), 151.2 (C-4), 156.2 (C-6), 165.1 (CO), 200.5 (C-1) ppm.
EI-MS: m/z (rel. int.)  584 (7) [M·], 343 (42), 253 (3), 251 (3),
181 (13), 91 (100). C38H32O6 (584.7): calcd. C 78.06, H 5.52; found
C 78.03, H 5.63.
4,6-Dibenzyloxy-2-(3,4-dibenzyloxycinnamoyloxy)acetophenone
(1i): Yield 83.1 % (4.93 g). M.p. 110111 °C (recrystallised from
ethanol). 1H NMR: δ  2.47 (s, 3 H, 2-CH3), 4.93 (s, 2 H, 6-
OCH2C6H5), 4.97 (s, 2 H, 4-OCH2C6H5), 5.10 and 5.14 (2s, 4 H,
3,4-OCH2C6H5), 6.38 (d, J  15.8 Hz, 1 H, α-H), 6.40 (d, J 
2.1 Hz, 1 H, 3-H), 6.48 (d, J  2.1 Hz, 1 H, 5-H), 6.86 (d, J 
8.3 Hz, 1 H, 5-H), 7.03 (d, J  8.3 Hz, 1 H, 6-H), 7.12 (br. s, 1
H, 2-H), 7.237.44 (m, 20 H, 2,3,4,5,6-H of 4,6,3,4-
OCH2C6H5), 7.71 (d, J  15.8 Hz, 1 H, β-H) ppm. 13C NMR: δ 
31.8 (C-2), 70.1 (6-OCH2C6H5), 70.5 and 70.9 (3,4-
OCH2C6H5), 70.6 (4-OCH2C6H5), 98.0 (C-5), 101.1 (C-3), 113.3
(C-2), 113.7 (C-5), 114.2 (C-α), 117.6 (C-1), 123.2 (C-6),
126.9, 127.0 and 127.2 (C-2,6 of 4,6,3,4-OCH2C6H5), 127.1
(C-1), 127.4 and 127.7 (C-4 of 4,6,3,4-OCH2C6H5), 128.0,
128.0, 128.3, and 128.4 (C-3,5 of 4,6,3,4-OCH2C6H5), 135.6
and 135.7 (C-1 of 4,6-OCH2C6H5), 136.4 and 136.6 (C-1 of
3,4-OCH2C6H5), 146.7 (C-β), 148.6 (C-3), 149.3 (C-2), 151.1
(C-4), 157.8 (C-6), 161.0 (C-4), 165.1 (CO), 199.4 (C-1) ppm.
EI-MS: m/z (rel. int.)  690 (1) [M·], 360 (1), 343 (18), 306 (2),
253 (2), 180 (8), 173 (7), 160 (8), 146 (5), 117 (2), 91 (100).
C45H38O7 (690.8): calcd. C 78.24, H 5.54; found C 78.26, H 5.53.
Synthesis of 5-Aryl-3-hydroxy-1-(2-hydroxyaryl)-2,4-pentadien-1-
ones 2ai: Potassium hydroxide (powder, 1.0 g, 25 mmol) was ad-
ded to a solution of the appropriate 2-cinnamoyloyacetophenone
1ai (5 mmol) in dimethyl sulfoxide (30 mL). The solution was
stirred under nitrogen at room temperature for 2 hours. After that
period, the solution was poured into ice and water (200 mL), and
the pH adjusted to 4 with dilute hydrochloric acid. The solid so-
obtained was removed by filtration, dissolved in dichloromethane
(20 mL), and purified by silica gel column chromatography using
dichloromethane as eluent. The solvent was evaporated to dryness
in each case, and the residue was crystallised from ethanol to give
the expected products 2ai.
1-(4-Benzyloxy-2-hydroxyphenyl)-3-hydroxy-5-phenyl-2,4-penta-
dien-1-one (2a): Yield 66.1 % (1.23 g). M.p. 168169 °C (recrystal-
lised from ethanol). 1H NMR: δ  5.09 (s, 2 H, 4-OCH2C6H5),
6.20 (s, 1 H, 2-H), 6.52 (br. s, 1 H, 3-H), 6.54 (d, J  8.3 Hz, 1 H,
5-H), 6.57 (dd, J  16.1, 0.8 Hz, 1 H, 4-H), 7.347.44 (m, 8 H,
3,4,5-H and 2,3,4,5,6-H of 4-OCH2C6H5), 7.55 (dd, J  7.6,
1.8 Hz, 2 H, 2,6-H), 7.62 (d, J  8.3 Hz, 1 H, 6-H), 7.61 (d,
J  16.1 Hz, 1 H, 5-H), 12.68 (s, 1 H, 2-OH), 14.52 (d, J  0.8 Hz,
1 H, 3-OH) ppm. 13C NMR: δ  70.2 (4-OCH2C6H5), 96.8 (C-2),
102.2 (C-3), 108.4 (C-5), 112.9 (C-1), 122.3 (C-4), 127.5, 127.9,
128.3, 128.7, and 128.9 (C-3,4,5 and C-2,3,4,5,6 of 4-
OCH2C6H5), 129.9 (C-6), 130.1 (C-2,6), 135.1 (C-1), 135.9
(C-1 of 4-OCH2C6H5), 139.0 (C-5), 164.9 (C-4), 165.3 (C-2),
173.1 (C-3), 194.6 (C-1) ppm. EI-MS: m/z (rel. int.)  372 (56)
[M·], 354 (3), 281 (7), 227 (27), 200 (4), 144 (4), 131 (49), 103 (15),
91 (100). C24H20O4 (372.4): calcd. C 77.40, H 5.41; found C 77.35,
H 5.41.
1-(6-Benzyloxy-2-hydroxyphenyl)-3-hydroxy-5-phenyl-2,4-penta-
dien-1-one (2b): Yield 90.9 % (1.69 g). M.p. 166168 °C (recrystal-
lised from ethanol). 1H NMR: δ  5.15 (s, 2 H, 6-OCH2C6H5),
6.16 (dd, J  16.0, 1.2 Hz, 1 H, 4-H), 6.49 (dd, J  8.3, 1.0 Hz, 1
H, 3-H), 6.62 (dd, J  8.3, 1.0 Hz, 1 H, 5-H), 6.86 (s, 1 H, 2-H),
7.32 (t, J  8.3 Hz, 1 H, 4-H), 7.48 (d, J  16.0 Hz, 1 H, 5-
H), 7.377.54 (m, 10 H, 2,3,4,5,6-H and 2,3,4,5,6-H of 2-
OCH2C6H5), 12.89 (s, 1 H, 2-OH), 14.63 (d, J  1.2 Hz, 1 H, 3-
OH) ppm. 13C NMR: δ  71.2 (6-OCH2C6H5), 102.2 (C-2), 102.8
(C-3), 110.6 (C-1), 111.4 (C-5), 122.8 (C-4), 127.8 (C-2,6),
128.1 (C-2,6 of 6-OCH2C6H5), 128.4 (C-4 of 6-OCH2C6H5), 128.7
(C-3,5), 128.8 (C-3,5 of 6-OCH2C6H5), 131.8 (C-4), 135.0 (C-
1), 135.2 (C-4), 136.0 (C-1 of 6-OCH2C6H5), 138.8 (C-5), 159.5
(C-6), 164.4 (C-2), 174.1 (C-3), 195.0 (C-1) ppm. EI-MS: m/z (rel.
int.)  372 (14) [M·], 354 (22), 281 (18), 226 (15), 223 (10), 194
(10), 137 (15), 131 (63), 103 (24), 91 (100). C24H20O4 (372.4): calcd.
C 77.40, H, 5.41; found C 77.11, H 5.44.
1-(4,6-Dibenzyloxy-2-hydroxyphenyl)-3-hydroxy-5-phenyl-2,4-
pentadien-1-one (2c): Yield 81.2 % (1.94 g). M.p. 134136 °C
(recrystallised from ethanol). 1H NMR: δ  5.08 and 5.09 (2s, 4
H, 4,6-OCH2C6H5), 6.13 (dd, J  15.8, 1.1 Hz, 1 H, 4-H), 6.14
(d, J  2.5 Hz, 1 H, 5-H), 6.20 (d, J  2.5 Hz, 1 H, 3-H), 6.82
(s, 1 H, 2-H), 7.44 (d, J  15.8 Hz, 1 H, 5-H), 7.377.51 (m, 15
H, 2,3,4,56-H and 2,3,4,5,6-H of 4,6-OCH2C6H5), 13.69
(s, 1 H, 2-OH), 14.46 (d, J  1.1 Hz, 1 H, 3-OH) ppm. 13C NMR:
δ 70.2 and 71.2 (4,6-OCH2C6H5), 92.9 (C-5), 95.2 (C-3), 103.4
(C-2), 104.9 (C-1), 123.1 (C-4), 127.7 and 127.7 (C-2,6 of 4,6-
OCH2C6H5), 128.2 (C-2,6), 128.4 and 128.5 (C-4 and C-4 of
6-OCH2C6H5), 128.7, 128.8 and 128.9 (C-3,5 and C-3,5 of
4,6-OCH2C6H5), 129.6 (C-4 of 4-OCH2C6H5), 135.3 (C-1),
135.8 and 135.9 (C-1 of 4,6-OCH2C6H5), 137.9 (C-5), 161.0 (C-
6), 164.6 (C-4), 167.3 (C-2), 172.9 (C-3), 193.8 (C-1) ppm. EI-
MS: m/z (rel. int.)  478 (9) [M·], 461 (9), 460 (14), 387 (11), 371
(7), 345 (1), 333 (5), 329 (6), 306 (6), 243 (8), 131 (35), 103 (13), 91
(100). C31H26O5 (478.5): calcd. C 77.81, H 5.48; found C 77.51,
H 5.36.
1-(4-Benzyloxy-2-hydroxyphenyl)-5-(4-benzyloxyphenyl)-3-hydroxy-
2,4-pentadien-1-one (2d): Yield 64.0 % (1.53 g). M.p. 171172 °C
(recrystallised from ethanol). 1H NMR: δ  5.08 and 5.10 (2s, 4
H, 4,4-OCH2C6H5), 6.15 (s, 1 H, 2-H), 6.44 (d, J  15.8 Hz, 1
H, 4-H), 6.51 (d, J  2.3 Hz, 1 H, 3-H), 6.53 (dd, J  7.4, 2.3 Hz,
1 H, 5-H), 6.99 (d, J  8.7 Hz, 1 H, 3,5-H), 7.267.45 (m, 10
H, 2,3,4,5,6-H of 4,4-OCH2C6H5), 7.49 (d, J  8.7 Hz, 2 H,
2,6-H), 7.57 (d, J  15.8 Hz, 1 H, 5-H), 7.61 (d, J  7.4 Hz, 1
H, 6-H), 12.73 (s, 1 H, 2-OH), 14.60 (s, 1 H, 3-OH) ppm. 13C
NMR: δ  70.0 and 70.1 (4 and 4-OCH2C6H5), 96.2 (C-2), 102.2
(C-3), 108.2 (C-5), 112.9 (C-1), 115.2 (C-3,5), 119.9 (C-4),
127.4 and 127.5 (C-2,6 of 4,4-OCH2C6H5), 128.1 and 128.2 (C-
4 of 4,4-OCH2C6H5), 128.6 (C-3,5 of 4,4-OCH2C6H5), 129.5
(C-2,6), 130.0 (C-6), 130.4 (C-1), 135.9 and 136.4 (C-1 of
4,4-OCH2C6H5), 138.8 (C-5), 160.2 (C-4), 164.7 (C-4), 165.1
(C-2), 173.7 (C-3), 194.3 (C-1) ppm. EI-MS: m/z (rel. int.)  478
(6) [M·], 460 (6), 251 (7), 237 (11), 227 (24), 197 (2), 147 (4), 91
(100). C31H26O5 (478.5): calcd. C 77.81, H 5.48; found C 77.51,
H 5.72.
1-(6-Benzyloxy-2-hydroxyphenyl)-5-(4-benzyloxyphenyl)-3-hydroxy-
2,4-pentadien-1-one (2e): Yield 95.0 % (2.27 g). M.p. 127128 °C
(recrystallised from ethanol). 1H NMR: δ  5.11 and 5.15 (2s, 4
H, 6,4-OCH2C6H5), 6.05 (d, J  15.7 Hz, 1 H, 4-H), 6.49 (d,
J  8.2 Hz, 1 H, 3-H), 6.61 (d, J  8.2 Hz, 1 H, 5-H), 6.83 (s, 1
H, 2-H), 6.99 (d, J  8.7 H, 2 H, 3,5-H), 7.31 (t, J  8.2 Hz, 1
H, 4-H), 7.357.53 (m, 12 H, 2,6-H and 2,3,4,5,6-H of 6,4-
OCH2C6H5), 7.46 (d, J  15.7 Hz, 1 H, 5-H), 12.91 (s, 1 H, 2-
OH), 14.76 (d, J  0.6 Hz, 1 H, 3-OH) ppm. 13C NMR: δ  70.0
and 71.2 (6,4-OCH2C6H5), 102.8 (C-3), 103.5 (C-2), 110.6 (C-
1), 111.4 (C-5), 115.2 (C-3,5), 120.5 (C-4), 127.4 and 128.0 (C-
2,6 of 6,4-OCH2C6H5), 128.1 and 128.3 (C-4 of 6,4-
OCH2C6H5), 128.6 and 128.7 (C-3,5 of 6,4-OCH2C6H5), 129.5
(C-2,6), 130.2 (C-1), 135.0 (C-4), 136.1 and 136.4 (C-1 of
6,4-OCH2C6H5), 138.6 (C-5), 159.4 (C-4), 160.2 (C-6), 164.3
(C-2), 174.8 (C-3), 194.5 (C-1) ppm. EI-MS: m/z (rel. int.)  478
(3) [M·], 460 (6), 387 (7), 371 (3), 300 (3), 237 (26), 226 (8), 197
(2), 147 (3), 137 (8), 91 (100). C31H26O5 (478.5): calcd. C 77.81, H
5.48; found C 77.79, H 5.52.
1-(4,6-Dibenzyloxy-2-hydroxyphenyl)-5-(4-benzyloxyphenyl)-3-
hydroxy-2,4-pentadien-1-one (2f): Yield 79.1 % (2.31 g). M.p.
178180 °C (recrystallised from ethanol). 1H NMR: δ  5.08,
5.09, and 5.12 (3s, 6 H, 4,6,4-OCH2C6H5), 6.01 (d, J  16.5 Hz,
1 H, 4-H), 6.14 (d, J  2.4 Hz, 1 H, 5-H), 6.20 (d, J  2.4 Hz, 1
H, 3-H), 6.79 (s, 1 H, 2-H), 6.98 (d, J  8.7 Hz, 2 H, 3,5-H),
7.267.54 (m, 17 H, 2,6-H and 2,3,4,5,6-H of 4,6,4-
OCH2C6H5), 7.43 (d, J  16.5 Hz, 1 H, 5-H), 13.72 (s, 1 H, 2-
OH), 14.57 (d, J  1.2 Hz, 1 H, 3-OH) ppm. 13C NMR: δ  70.1,
70.2, and 71.2 (4,6,4-OCH2C6H5), 92.9 (C-5), 95.2 (C-3), 102.8
(C-2), 105.2 (C-1), 115.2 (C-3,5), 120.9 (C-4), 127.5 (C-2,6 of
4,6,4-OCH2C6H5), 127.7 (C-4 of 4,6,4-OCH2C6H5), 128.7
(C-2,6), 129.3 (C-3,5 of 4,6,4-OCH2C6H5), 135.9 (C-1 and
C-1 of 4,6,4-OCH2C6H5), 137.8 (C-5), 160.1 (C-4), 160.9 (C-
6), 160.5 (C-4), 167.2 (C-2), 173.6 (C-3), 193.5 (C-1) ppm. EI-
MS: m/z (rel. int.)  584 (1) [M·], 566 (2), 493 (1), 476 (3), 333
(1), 306 (3), 268 (1), 252 (1), 243 (1), 237 (5), 215 (1), 181 (2), 147
(4), 133 (2), 121 (3), 107 (1), 105 (2), 91 (100). C38H32O6 (584.7):
calcd. C 78.06, H 5.52; found C 78.02, H 5.53.
1-(4-Benzyloxy-2-hydroxyphenyl)-5-(3,4-dibenzyloxyphenyl)-3-
hydroxy-2,4-pentadien-1-one (2g): Yield 83.9 % (2.45 g). M.p.
142143 °C (recrystallised from ethanol). 1H NMR: δ  5.07 (s,
2 H, 4-OCH2C6H5), 5.19 (s, 4 H, 3,4-OCH2C6H5), 6.14 (s, 1 H,
2-H), 6.36 (d, J  15.7 Hz, 1 H, 4-H), 6.51 (d, J  2.4 Hz, 1 H,
3-H), 6.52 (d, J  6.9, 2.4 Hz, 1 H, 5-H), 6.92 (d, J  8.3 Hz, 1
H, 5-H), 7.08 (dd, J  8.3, 1.7 Hz, 1 H, 6-H), 7.13 (d, J 
1.7 Hz, 1 H, 2-H), 7.257.52 (m, 15 H, 2,3,4,5,6-H of 4,3,4-
OCH2C6H5), 7.49 (d, J  15.7 Hz, 1 H, 5-H), 7.59 (d, J  6.9 Hz,
1 H, 6-H), 12.71 (s, 1 H, 2-OH), 14.57 (s, 1 H, 3-OH) ppm. 13C
NMR: δ  70.1 (4-OCH2C6H5), 70.9 and 71.3 (3,4-
OCH2C6H5), 96.3 (C-2), 102.2 (C-3), 108.3 (C-5), 112.9 (C-1),
113.6 (C-2), 114.3 (C-5), 120.3 (C-4), 122.6 (C-6), 127.1, 127.3,
127.5, 127.9, 128.2, 128.5 and 128.7 (C-2,3,4,5,6 of 4,3,4-
OCH2C6H5), 128.3 (C-1), 130.0 (C-6), 135.9 (C-1 of 4-
OCH2C6H5), 136.7 and 136.9 (C-1 of 3,4-OCH2C6H5), 138.9
(C-5), 149.0 (C-3), 150.8 (C-4), 164.8 (C-4), 165.2 (C-2), 173.6
(C-3), 194.3 (C-1) ppm. EI-MS: m/z (rel. int.)  584 (3) [M·], 566
(3), 475 (4), 317 (2), 227 (9), 181 (2), 91 (100). C38H32O6 (584.7):
calcd. C 78.06, H 5.52; found C 78.00, H 5.49.
1-(6-Benzyloxy-2-hydroxyphenyl)-5-(3,4-dibenzyloxyphenyl)-3-
hydroxy-2,4-pentadien-1-one (2 h): Yield 81.2 % (2.37 g). M.p.
152154 °C (recrystallised from ethanol). H NMR: δ  5.15, 5.17,
and 5.20 (3s, 6 H, 6,3,4-OCH2C6H5), 6.02 (d, J  15.7 Hz, 1
H, 4-H), 6.49 (d, J  8.1 Hz, 1 H, 3-H), 6.61 (dd, J  8.3, 0.7 Hz,
1 H, 5-H), 6.84 (s, 1 H, 2-H), 6.92 (d, J  8.4 Hz, 1 H, 6-H),
7.00 (dd, J  8.4, 1.8 Hz, 1 H, 5-H), 7.05 (d, J  1.8 Hz, 1 H,
2-H), 7.287.53 (m, 16 H, 4-H and 2,3,4,5,6-H of 6,3,4-
OCH2C6H5), 7.41 (d, J  15.7 Hz, 1 H, 5-H), 12.92 (s, 1 H, 2-
OH), 14.77 (s, 1 H, 3-OH) ppm. 13C NMR: δ  71.0, 71.2, and
71.5 (6,3,4-OCH2C6H5), 102.8 (C-3), 103.6 (C-2), 110.7 (C-1),
111.4 (C-5), 113.8 (C-2), 114.3 (C-5), 120.8 (C-4), 122.8 (C-6),
127.2, 127.4, 128.0, 128.3, 128.6 and 128.7 (C-2,3,4,5,6 of 6,3,4-
OCH2C6H5), 135.0 (C-4), 136.2, 136.7, and 136.9 (C-1 and C-1
of 6,3,4-OCH2C6H5), 138.8 (C-5), 149.0 (C-3), 150.9 (C-4),
159.4 (C-6), 164.3 (C-2), 174.7 (C-3), 194.6 (C-1) ppm. EI-MS:
m/z (rel. int.)  584 (3) [M·], 566 (2), 493 (3), 476 (4), 385 (3), 343
(4), 227 (6), 181 (6), 137 (8), 108 (1), 91 (100). C38H32O6 (584.7):
calcd. C 78.06, H 5.52; found C 78.04, H 5.50.
1-(4,6-Dibenzyloxy-2-hydroxyphenyl)-5-(3,4-dibenzyloxyphenyl)-3-
hydroxy-2,4-pentadien-1-one (2i): Yield 64.9 % (2.24 g). M.p.
175176 °C (recrystallised from ethanol). 1H NMR: δ  5.07 (s,
2 H, 6-OCH2C6H5), 5.09 (s, 2 H, 4-OCH2C6H5), 5.17 (s, 2 H, 3-
OCH2C6H5), 5.21 (s, 2 H, 4-OCH2C6H5), 5.99 (d, J  15.7 Hz, 1
H, 4-H), 6.13 (d, J  2.3 Hz, 1 H, 5-H), 6.20 (d, J  2.3 Hz, 1 H,
3-H), 6.80 (s, 1 H, 2-H), 6.92 (d, J  8.3 Hz, 1 H, 5-H), 6.99
(dd, J  8.3, 1.8 Hz, 1 H, 6-H), 7.04 (d, J  1.8 Hz, 1 H, 2-H),
7.35 (d, J  15.7 Hz, 1 H, 5-H), 7.267.53 (m, 20 H, 2,3,4,5,6-H
of 4,6,3,4-OCH2C6H5), 13.73 (s, 1 H, 2-OH), 14.59 (d, J 
0.8 Hz, 1 H, 3-OH) ppm. 13C NMR: δ  70.2 (6-OCH2C6H5),
71.0 (4-OCH2C6H5), 71.1 (4-OCH2C6H5), 71.5 (3-OCH2C6H5),
92.9 (C-5), 95.2 (C-3), 102.9 (C-2), 104.9 (C-1), 113.7 (C-2),
114.3 (C-5), 121.1 (C-4), 122.6 (C-6), 127.2, 127.4, 127.7, and
128.1 (C-1 and C-2,6 of 4,6,3,4-OCH2C6H5), 127.9, 128.0,
and 128.3 (C-4 of 4,6,3,4-OCH2C6H5), 128.6, 128.7, 128.7, and
128.9 (C-3,5 of 4,6,3,4-OCH2C6H5), 135.9 and 136.9 (C-1 of
4,6,3,4-OCH2C6H5), 137.9 (C-5), 149.0 (C-3), 150.6 (C-4),
160.9 (C-6), 164.5 (C-4), 167.2 (C-2), 173.5 (C-3), 193.5 (C-1)
ppm. EI-MS: m/z (rel. int.)  690 (1) [M·], 672 (1), 582 (1), 491
(2), 358 (3), 306 (7), 267 (3), 243 (1), 215 (2), 181 (8), 91 (100).
C45H38O7 (690.8): calcd. C 78.24, H 5.54; found C 78.16, H 5.54.
Synthesis of Benzyloxy-2-styrylchromones 3ai. Method 1: A cata-
lytic amount of iodine (254 mg, 1 mmol) was added to a solution
of the appropriate 5-aryl-3-hydroxy-1-(2-hydroxyaryl)-2,4-pen-
tadien-1-one 2ai (5 mmol) in dimethyl sulfoxide (30 mL). The
solution was heated under nitrogen at 90 °C, until the complete
consumption of the starting material was observed. After that per-
iod, the solution was poured into ice and a saturated aqueous solu-
tion of sodium thiosulfate (100 mL). The solid was removed by
filtration, dissolved in dichloromethane (50 mL) and washed with
a saturated aqueous solution of sodium thiosulfate (2  20 mL).
After evaporation of the solvent, the residue was purified by silica
gel column chromatography using a mixture of light petroleum:-
dichloromethane (1:1) as eluent. The solvent was evaporated to
dryness in each case, and the residue was crystallised from ethanol
to give benzyloxy-2-styrylchromones 3ai in the following yields:
3a (74.0 %, 1.31 g), 4b (9.0 %, 218 mg), 3c (37.0 %, 851 mg) and 4c
(4.0 %, 118 mg), 3d (9.0 %, 207 mg) and 4d (9.0 %, 313 mg), 3e
(4 %, 92 mg) and 4e (3.0 %, 105 mg), 3f (56.9 %, 1.61 g) and 4f
(5.0 %, 201 mg), 3g (62.9 %, 1.78 g), 3h (47.0 %, 1.33 g), 3i
(50.9 %, 1.71 g).
Method 2: p-Toluenesulfonic acid monohydrate (0.48 g, 2.5 mmol)
was added to a solution of the appropriate 5-aryl-3-hydroxy-1-(2-
hydroxyaryl)-2,4-pentadien-1-one 2ai (5 mmol) in dimethyl sul-
foxide (30 mL). The solution was heated under nitrogen at 90 °C,
until the complete consumption of the starting material was ob-
served. After that period, the solution was poured into ice and
water (100 mL), and the solid so-obtained was removed by fil-
tration. The solid was dissolved in dichloromethane (50 mL) and
the organic phase washed with water (2  100 mL). After evapor-
ation of the solvent, the residue was purified by silica gel column
chromatography using a mixture of light petroleum:dichlorome-
thane (1:1) as eluent. The solvent was evaporated to dryness in
each case, and the residue was crystallised from ethanol to give
the benzyloxy-2-styrylchromones 3ai in the following yields: 3a
(19.0 %, 336 mg) and 4a (22.0 %, 532 mg), 3b (93.2 %, 1.65 g), 3c
(19.0 %, 437 mg) and 4c (48.8 %, 1.44 g), 3d (96.1 %, 2.21 g), 3e
(95.2 %, 2.19 g), 3f (82.0 %, 2.32 g), 3g (96.1 %, 2.72 g), 3h (84.1 %,
2.38 g), 3i (83.9 %, 2.82 g).
7-Benzyloxy-2-styrylchromone (3a): M.p. 161163 °C (recrystal-
lised from ethanol). 1H NMR: δ  5.16 (s, 2 H, 7-OCH2C6H5),
6.24 (s, 1 H, 3-H), 6.72 (d, J  16.2 Hz, 1 H, α-H), 6.99 (br. s, 1
H, 8-H), 7.02 (dd, J  8.8, 2.3 Hz, 1 H, 6-H), 7.347.57 (m, 10
H, 2,3,4,5,6-H and 2,3,4,5,6-H of 7-OCH2C6H5), 7.53 (d, J 
16.2 Hz, 1 H, β-H), 8.08 (d, J  8.8 Hz, 1 H, 5-H) ppm. 13C NMR:
δ  70.4 (7-OCH2C6H5), 101.2 (C-8), 110.6 (C-3), 114.5 (C-6),
118.1 (C-10), 120.2 (C-α), 127.0 (C-5), 127.4 (C-2,6 of 7-
OCH2C6H5), 127.5 (C-2,6), 128.3 (C-4 of 7-OCH2C6H5), 128.7
(C-3,5 of 7-OCH2C6H5), 128.9 (C-3,5), 129.7 (C-4), 134.9 (C-1),
135.7 (C-1 of 7-OCH2C6H5), 136.2 (C-β), 157.5 (C-9), 161.2 (C-2),
163.1 (C-7), 177.7 (C-4) ppm. EI-MS: m/z (rel. int.)  354 (69)
[M·], 263 (8), 235 (13), 178 (8), 128 (10), 103 (6), 91 (100).
C24H18O3 (354.4): calcd. C 81.34, H 5.12; found C 81.23, H 5.08.
5-Benzyloxy-2-styrylchromone (3b): M.p. 179181 °C (recrystal-
lised from ethanol). 1H NMR: δ  5.28 (s, 2 H, 5-OCH2C6H5),
6.24 (s, 1 H, 3-H), 6.74 (d, J  16.0 Hz, 1 H, α-H), 6.83 (d, J 
8.3 Hz, 1 H, 6-H), 7.11 (d, J  8.3 Hz, 1 H, 8-H), 7.29 (t, J 
7.3 Hz, 1 H, 4-H of 5-OCH2C6H5), 7.377.44 (m, 5 H, 3,4,5-H
and 3,5-H of 5-OCH2C6H5), 7.51 (t, J  8.3 Hz, 1 H, 7-H), 7.54
(d, J  16.0 Hz, 1 H, β-H), 7.57 (dd, J  7.7, 1.4 Hz, 2 H, 2,6-
H), 7.63 (d, J  7.3 Hz, 2 H, 2,6-H of 5-OCH2C6H5) ppm. 13C
NMR: δ  70.8 (5-OCH2C6H5), 108.3 (C-6), 110.3 (C-8), 112.3 (C-
3), 115.2 (C-10), 119.9 (C-α), 126.6 (C-2,6 of 5-OCH2C6H5), 127.5
(C-2,6), 127.6 (C-4 of 5-OCH2C6H5), 128.5 (C-3,5 of 5-
OCH2C6H5), 128.9 (C-3,5), 129.6 (C-4), 133.6 (C-7), 135.0 (C-
1), 136.2 (C-β), 136.6 (C-1 of 5-OCH2C6H5), 158.0 (C-9), 158.5
(C-5), 159.5 (C-2), 178.1 (C-4) ppm. EI-MS: m/z (rel. int.)  354
(91) [M·], 353 (17), 277 (14), 264 (11), 248 (55), 247 (49), 231 (21),
218 (24), 91 (100). C24H18O3 (354.4): calcd. C 81.34, H 5.12; found
C 81.54, H 5.02.
5,7-Dibenzyloxy-2-styrylchromone (3c): M.p. 161163 °C (recrys-
tallised from ethanol). 1H NMR: δ  5.07 (s, 2 H, 7-OCH2C6H5),
5.14 (s, 2 H, 5-OCH2C6H5), 6.13 (s, 1 H, 3-H), 6.42 (d, J  2.2 Hz,
1 H, 6-H), 6.58 (d, J  2.2 Hz, 1 H, 8-H), 6.63 (d, J  16.0 Hz, 1
H, α-H), 7.247.44 (m, 9 H, 3,4,5-H and 3,4,5-H of 5,7-
OCH2C6H5), 7.43 (d, J  16.0 Hz, 1 H, β-H), 7.50 (dd, J  7.2,
1.7 Hz, 4 H, 2,6-H and 2,6-H of 7-OCH2C6H5), 7.60 (d, J 
7.4 Hz, 2 H, 2,6-H of 5-OCH2C6H5) ppm. 13C NMR: δ  70.3 (7-
OCH2C6H5), 70.4 (5-OCH2C6H5), 93.9 (C-8), 97.9 (C-6), 109.8 (C-
10), 112.2 (C-3), 119.8 (C-α), 126.4 (C-2,6 of 5-OCH2C6H5), 127.4
(C-4 of 5-OCH2C6H5), 127.4 and 127.5 (C-2,6 and C-2,6 of 7-
OCH2C6H5), 128.3 (C-4 of 7-OCH2C6H5), 128.4, 128.6, and 128.8
(C-3,5 and C-3,5 of 5,7-OCH2C6H5), 129.4 (C-4), 135.0 (C-1),
135.5 (C-β), 135.6 (C-1 of 7-OCH2C6H5), 136.2 (C-1 of 5-
OCH2C6H5), 158.9 (C-2), 159.3 (C-9), 159.5 (C-5), 162.8 (C-7),
177.2 (C-4) ppm. EI-MS: m/z (rel. int.)  460 (8) [M·], 383 (4),
370 (18), 354 (12), 341 (9), 263 (3), 235 (2), 155 (1), 131 (4), 128
(4), 123 (3), 115 (3), 91 (100). C31H24O4 (460.5): calcd. C 80.85, H
5.25; found C 80.48, H 5.19.
7,4-Dibenzyloxy-2-styrylchromone (3d): M.p. 148150 °C (recrys-
tallised from ethanol). 1H NMR: δ  5.10 (s, 2 H, 4-OCH2C6H5),
5.18 (s, 2 H, 7-OCH2C6H5), 6.22 (s, 1 H, 3-H), 6.61 (d, J 16.0 Hz,
1 H, α-H), 6.997.03 (m, 4 H, 6,8,3,5-H), 7.257.45 (m, 10 H,
2,3,4,5,6-H of 7,4-OCH2C6H5), 7.51 (d, J  8.7 Hz, 2 H, 2,6-H),
7.50 (d, J  16.0 Hz, 1 H, β-H), 8.10 (d, J  8.5 Hz, 1 H, 5-H)
ppm. 13C NMR: δ  70.1 (4-OCH2C6H5), 70.5 (7-OCH2C6H5),
101.3 (C-8), 110.0 (C-3), 114.5 (C-3,5), 115.3 (C-6), 118.0 (C-α),
118.2 (C-10), 127.1 (C-1), 127.5 (C-5), 127.5 and 128.1 (C-2,6 of
7,4-OCH2C6H5), 128.2 and 128.4 (C-4 of 7,4-OCH2C6H5), 128.7
and 128.8 (C-3,5, of 7,4-OCH2C6H5), 129.2 (C-2,6), 135.8 (C-1
of 7-OCH2C6H5), 136.0 (C-β), 136.4 (C-1 of 4-OCH2C6H5), 157.6
(C-9), 160.1 (C-4), 161.8 (C-2), 163.1 (C-7), 177.9 (C-4) ppm. EI-
MS: m/z (rel. int.)  460 (28) [M·], 443 (1), 370 (7), 354 (4), 341
(2), 263 (2), 165 (2), 115 (2), 107 (1), 91 (100). C31H24O4 (460.5):
calcd. C 80.85, H 5.25; found C 80.69, H 5.16.
5,4-Dibenzyloxy-2-styrylchromone (3e): M.p. 154156 °C (recrys-
tallised from ethanol). 1H NMR: δ  5.09 (s, 2 H, 5-OCH2C6H5),
5.26 (s, 2 H, 4-OCH2C6H5), 6.19 (s, 1 H, 3-H), 6.58 (d, J 
15.8 Hz, 1 H, α-H), 6.81 (d, J  8.5 Hz, 1 H, 6-H), 6.99 (d, J 
8.7 Hz, 2 H, 3,5-H), 7.08 (d, J  8.5 Hz, 1 H, 8-H), 7.277.42
(m, 10 H, 2,6-H, 3,4,5-H of 5-OCH2C6H5 and 2,3,4,5,6-H of 4-
OCH2C6H5), 7.47 (d, J  15.8 Hz, 1 H, β-H), 7.48 (t, J  8.5 Hz,
1 H, 7-H), 7.63 (d, J  7.4 Hz, 2 H, 2,6-H of 5-OCH2C6H5) ppm.
13C NMR: δ  70.0 (5-OCH2C6H5), 70.7 (4-OCH2C6H5), 108.2
(C-6), 110.2 (C-8), 111.6 (C-3), 115.2 (C-10,3,5), 117.6 (C-α),
126.5 (C-2,6 of 5-OCH2C6H5), 127.4 (C-2,6 of 4-OCH2C6H5),
127.5 and 128.1 (C-4 of 5,4-OCH2C6H5), 128.0 (C-1), 128.5 and
128.6 (C-3,5, of 5,4-OCH2C6H5), 129.1 (C-2,6), 133.4 (C-7),
135.8 (C-β), 136.4 and 136.6 (C-1 of 5, 4-OCH2C6H5), 158.0 (C-
9), 158.4 (C-4), 159.9 (C-2), 160.0 (C-5), 178.1 (C-4) ppm. EI-MS:
m/z (rel. int.)  460 (33) [M·], 370 (8), 354 (5), 263 (2), 115 (1),
91 (100). C31H24O4 (460.5): calcd. C 80.85, H 5.25; found C 80.53,
H 4.89.
5,7,4-Tribenzyloxy-2-styrylchromone (3f): M.p. 170172 °C
(recrystallised from ethanol). 1H NMR: δ  5.12 (s, 2 H, 4-
OCH2C6H5), 5.13 (s, 2 H, 7-OCH2C6H5), 5.22 (s, 2 H, 5-
OCH2C6H5), 6.15 (s, 1 H, 3-H), 6.49 (d, J  2.2 Hz, 1 H, 6-H),
6.59 (d, J  15.8 Hz, 1 H, α-H), 6.64 (d, J  2.2 Hz, 1 H, 8-H),
7.01 (d, J  8.7 Hz, 2 H, 3,5-H), 7.307.48 (m, 15 H, 5,7,4-
OCH2C6H5), 7.43 (d, J  15.8 Hz, 1 H, β-H), 7.51 (d, J  8.7 Hz,
2 H, 2,6-H), 7.62 (d, J  7.4 Hz, 2 H, 2,6-H of 5-OCH2C6H5)
ppm. 13C NMR: δ  70.1 (4-OCH2C6H5), 70.4 (7-OCH2C6H5),
70.6 (5-OCH2C6H5), 94.1 (C-8), 98.1 (C-6), 110.0 (C-10), 111.7 (C-
3), 115.2 (C-3,5), 117.7 (C-α), 126.5 (C-2,6 of 5-OCH2C6H5),
127.5 and 127.6 (C-2,6 of 7,4-OCH2C6H5), 127.6 (C-4 of 5-
OCH2C6H5), 128.1 and 128.4 (C-4 of 7,4-OCH2C6H5), 128.2 (C-
1), 128.6, 128.7, and 128.8 (C-3,5 of 5,7,4-OCH2C6H5), 129.0 (C-
2,6), 135.2 (C-β), 135.7, 136.4, and 136.5 (C-1 of 5,7,4-
OCH2C6H5), 159.5 (C-2,9), 159.6 (C-5), 160.0 (C-4), 162.8 (C-7),
177.4 (C-4) ppm. EI-MS: m/z (rel. int.)  566 (3) [M·], 476 (7),
386 (1), 147 (5), 133 (3), 121 (4), 107 (4), 105 (3), 91 (100).
C38H30O5 (566.7): calcd. C 80.55, H 5.34; found C 80.49, H 5.10.
7,3,4-Tribenzyloxy-2-styrylchromone (3g): M.p. 161163 °C
(recrystallised from ethanol). 1H NMR: δ  5.19 (s, 2 H, 7-
OCH2C6H5), 5.22 (s, 2 H, 3-OCH2C6H5), 5.23 (s, 2 H, 4-
OCH2C6H5), 6.22 (s, 1 H, 3-H), 6.54 (d, J  15.9 Hz, 1 H, α-H),
6.95 (d, J  8.3 Hz, 1 H, 5-H), 7.007.02 (m, 1 H, 6-H), 7.05 (d,
J  2.3 Hz, 1 H, 8-H), 7.10 (dd, J  8.3, 1.9 Hz, 1 H, 6-H), 7.17
(d, J  1.9 Hz, 1 H, 2-H), 7.327.50 (m, 15 H, 2,3,4,5,6-H of
7,3,4-OCH2C6H5), 7.43 (d, J  15.9 Hz, 1 H, β-H), 8.11 (d, J 
8.7 Hz, 1 H, 5-H) ppm. 13C NMR: δ  70.5 (7-OCH2C6H5), 71.0
(3-OCH2C6H5), 71.4 (4-OCH2C6H5), 101.3 (C-8), 110.1 (C-3),
113.3 (C-2), 114.4 (C-5), 114.5 (C-6), 118.2 (C-10), 118.3 (C-α),
122.3 (C-6), 127.2, 127.3, and 127.5 (C-2,6 of 7,3,4-OCH2C6H5),
127.5 (C-5), 128.0 and 128.4 (C-1 and C-4 of 7,3,4-OCH2C6H5),
128.6 and 128.8 (C-3,5 of 7,3,4-OCH2C6H5), 135.8, 136.7, and
136.9 (C-1 of 7,3,4-OCH2C6H5), 136.1 (C-β), 149.1 (C-3), 150.6
(C-4), 157.6 (C-9), 161.7 (C-2), 163.2 (C-7), 177.8 (C-4) ppm. EI-
MS: m/z (rel. int.)  566 (9) [M·], 475 (11), 131 (3), 118 (2), 106
(15), 91 (100). C38H30O5 (566.6): calcd. C 80.55, H 5.34; found C
80.24, H 5.50.
5,3,4-Tribenzyloxy-2-styrylchromone (3h): M.p. 172173 °C
(recrystallised from ethanol). 1H NMR: δ  5.21 and 5.22 (2s, 4
H, 3,4-OCH2C6H5), 5.28 (s, 2 H, 5-OCH2C6H5), 6.19 (s, 1 H, 3-
H), 6.52 (d, J  15.9 Hz, 1 H, α-H), 6.83 (d, J  8.0 Hz, 1 H, 6-
H), 6.94 (d, J  8.2 Hz, 1 H, 5-H), 7.09 (d, J  8.0 Hz, 1 H, 8-
H), 7.11 (dd, J  8.2, 1.8 Hz, 1 H, 6-H), 7.17 (d, J  1.8 Hz, 1
H, 2-H), 7.307.53 (m, 14 H, 7-H, 3,4,5-H of 5-OCH2C6H5 and
2,3,4,5,6-H of 3,4-OCH2C6H5), 7.42 (d, J  15.9 Hz, 1 H, β-H),
7.63 (d, J  7.4 Hz, 2 H, 2,6-H of 5-OCH2C6H5) ppm. 13C NMR:
δ  70.8 and 71.4 (3,4-OCH2C6H5), 71.0 (5-OCH2C6H5), 108.3
(C-6), 110.3 (C-8), 111.8 (C-3), 113.3 (C-2), 114.4 (C-5), 115.2 (C-
10), 118.0 (C-α), 122.3 (C-6), 126.6 (C-2,6 of 5-OCH2C6H5), 127.2
and 127.3 (C-2,6 of 3,4-OCH2C6H5), 127.6 and 128.0 (C-4 of
5,3,4-OCH2C6H5), 128.4 and 128.7 (C-3,5 of 5,3,4-OCH2C6H5),
128.6 (C-1), 133.5 (C-7), 136.0 (C-β), 136.6, 136.8, and 136.9 (C-
1 of 5,3,4-OCH2C6H5), 149.1 (C-3), 150.6 (C-4), 158.1 (C-9),
158.5 (C-5), 159.8 (C-2), 178.2 (C-4) ppm. EI-MS: m/z (rel. int.) 
566 (9) [M·], 476 (9), 385 (5), 181 (3), 106 (3), 91 (100). C38H30O5
(566.6): calcd. C 80.55, H 5.34; found C 80.47, H 5.67.
5,7,3,4-Tetrabenzyloxy-2-styrylchromone (3i): M.p. 9294 °C
(recrystallised from ethanol). 1H NMR: δ  5.12 (s, 2 H, 7-
OCH2C6H5), 5.21 and 5.22 (2s, 6 H, 5,3,4-OCH2C6H5), 6.13 (s, 1
H, 3-H), 6.48 (d, J  2.3 Hz, 1 H, 6-H), 6.50 (d, J  15.9 Hz, 1
H, α-H), 6.62 (d, J  2.3 Hz, 1 H, 8-H), 6.94 (d, J  8.4 Hz, 1 H,
5-H), 7.10 (dd, J  8.4, 1.9 Hz, 1 H, 6-H), 7.16 (d, J  1.9 Hz,
1 H, 2-H), 7.36 (d, J  15.9 Hz, 1 H, β-H), 7.277.50 (m, 13 H,
3,4,5-H of 5-OCH2C6H5 and 7,4-OCH2C6H5), 7.62 (d, J 7.2 Hz,
2 H, 2,6-H of 5-OCH2C6H5) ppm. 13C NMR: δ  70.5, 70.7, 71.0,
and 71.4 (5,7,3,4-OCH2C6H5), 94.1 (C-8), 98.1 (C-6), 110.0 (C-
10), 111.8 (C-3), 113.3 (C-2), 114.4 (C-5), 118.1 (C-α), 122.1 (C-
6), 126.5 (C-2,6 of 5-OCH2C6H5), 127.2, 127.3, and 127.6 (C-2,6
of 7,3,4-OCH2C6H5), 128.0 and 128.4 (C-4 of 5,7,3,4-
OCH2C6H5), 128.6 (C-1), 128.6, 128.8 (C-3,5 of 5,7,3,4-
OCH2C6H5), 135.4 (C-β), 135.7 (C-1 of 7-OCH2C6H5), 136.4,
136.8, and 136.9 (C-1 of 5,3,4-OCH2C6H5), 149.1 (C-3), 150.5
(C-4), 159.4 (C-2), 159.5 (C-9), 159.7 (C-5), 162.9 (C-7), 177.4 (C-
4) ppm. EI-MS: m/z (rel. int.)  672 (3) [M·], 582 (5), 491 (5), 292
(12), 277 (11), 263 (10), 247 (4), 181 (4), 115 (7), 106 (3), 91 (100).
C45H36O6 (672.8): calcd. C 80.34, H 5.39; found C 80.30, H. 5.66.
7-Benzyloxy-3-cinnamoyl-2-styrylchromone (4a): M.p. 8283 °C
(recrystallised from ethanol). 1H NMR: δ  5.23 (s, 2 H, 7-
OCH2C6H5), 7.07 (br. s, 1 H, 8-H), 7.09 (dd, J  7.6, 2.1 Hz, 1 H,
6-H), 7.17 (d, J  15.9 Hz, 1 H, α-H), 7.26 (d, J  15.9 Hz, 1 H,
α-H), 7.377.51 (m, 11 H, 3,4,5-H, 3,4,5-H and 2,3,4,5,6-
H of 7-OCH2C6H5), 7.577.64 (m, 4 H, 2,6-H and 2,6-H),
7.67 (d, J  15.9 Hz, 1 H, β-H), 7.74 (d, J  15.9 Hz, 1 H, β-
H), 8.15 (d, J  7.6 Hz, 1 H, 5-H) ppm. 13C NMR: δ  70.6 (7-
OCH2C6H5), 101.2 (C-8), 115.1 (C-6), 117.8 (C-10), 118.0 (C-α),
122.2 (C-3), 127.5 (C-α), 128.1 (C-5), 128.4, 128.7, 128.8, and
128.9 (C-3,4,5,3,4,5 and C-2,3,4,5,6 of 7-OCH2C6H5), 130.2
(C-2,6), 130.6 (C-2,6), 134.6 (C-1), 134.9 (C-1), 135.6 (C-1
of 7-OCH2C6H5), 139.1 (C-β), 144.2 (C-β), 156.9 (C-9), 161.1 (C-
2), 163.7 (C-7), 175.8 (C-4), 192.1 (CO) ppm. EI-MS: m/z (rel.
int.)  484 (55) [M·], 483 (8), 407 (17), 393 (5), 365 (6), 131 (9),
122 (7), 103 (15), 91 (100), 77 (8), 65 (8). C33H24O4 (484.5): calcd.
C 81.80, H 4.99; found C 81.84, H. 4.97.
5-Benzyloxy-3-cinnamoyl-2-styrylchromone (4b): M.p. 184186 °C
(recrystallised from ethanol). 1H NMR: δ  5.31 (s, 2 H, 5-
OCH2C6H5), 6.88 (d, J  8.2 Hz, 1 H, 6-H), 7.15 (d, J  8.2 Hz,
1 H, 8-H), 7.06 (d, J  15.9 Hz, 1 H, α-H), 7.25 (d, J  16.0 Hz,
1 H, α-H), 7.317.40 (m, 9 H, 3,4,5,3,4,5-H and 3,4,5-H
of 5-OCH2C6H5), 7.547.62 (m, 7 H, 7,2,6,2,6-H and 2,6-H
of 5-OCH2C6H5), 7.69 (d, J  16.0 Hz, 1 H, β-H), 7.71 (d, J 
15.9 Hz, 1 H, β-H) ppm. 13C NMR: δ  71.0 (5-OCH2C6H5), 108.7
(C-6), 110.2 (C-8), 114.9 (C-10), 117.8 (C-α), 123.7 (C-3), 126.6 (C-
2,6 of 5-OCH2C6H5), 127.6 (C-α), 127.7 (C-4 of 5-OCH2C6H5),
128.1 (C-2,6), 128.6 (C-2,6), 128.8 (C-3,5 and C-3,5 of 5-
OCH2C6H5), 128.9 (C-3,5), 130.1 (C-4), 130.6 (C-4), 134.2 (C-
1), 134.6 (C-1), 135.0 (C-7), 136.3 (C-1 of 5-OCH2C6H5), 139.0
(C-β), 144.2 (C-β), 157.3 (C-9), 158.8 (C-5), 159.1 (C-2), 176.2 (C-
4), 192.4 (CO) ppm. EI-MS: m/z (rel. int.)  484 (41) [M·], 393
(100), 365 (11), 291 (13), 127 (17), 103 (16), 91 (100), 77 (16), 65
(15). C33H24O4 (484.5): calcd. C 81.80, H 4.99; found C 81.71, H.
5.03.
5,7-Dibenzyloxy-3-cinnamoyl-2-styrylchromone (4c): M.p. 194196
°C (recrystallised from ethanol). 1H NMR: δ  5.16 (s, 2 H, 7-
OCH2C6H5), 5.24 (s, 2 H, 5-OCH2C6H5), 6.53 (d, J  2.0 Hz, 1
H, 6-H), 6.69 (d, J  2.0 Hz, 1 H, 8-H), 7.04 (d, J  15.9 Hz, 1
H, α-H), 7.25 (d, J  15.9 Hz, 1 H, α-H), 7.287.46 (m, 14 H,
3,4,5,3,4,5-H, 3,4,5-H of 5-OCH2C6H5 and 2,3,4,5,6-H of
7-OCH2C6H5), 7.557.61 (m, 6 H, 2,6,2,6-H and 2,6-H of 5-
OCH2C6H5), 7.66 (d, J  15.9 Hz, 1 H, β-H), 7.68 (d, J 
15.9 Hz, 1 H, β-H) ppm. 13C NMR: δ  70.6 (7-OCH2C6H5), 70.8
(5-OCH2C6H5), 94.0 (C-8), 98.5 (C-6), 109.6 (C-10), 117.8 (C-α),
123.6 (C-3), 126.6 (C-2,6 of 5-OCH2C6H5), 127.2 (C-2,6 of 7-
OCH2C6H5), 128.0 (C-α), 128.5, 128.6, 128.7, 128.8, and 128.9 (C-
3,4,5 and 3,4,5 and C-3,4,5 of 5,7-OCH2C6H5), 130.0 (C-
2,6), 130.5 (C-2,6), 134.7 (C-1), 135.0 (C-1), 135.5 (C-1 of
7-OCH2C6H5), 136.1 (C-1 of 5-OCH2C6H5), 138.3 (C-β), 144.0 (C-
β), 158.6 (C-2), 158.8 (C-9), 160.0 (C-5), 163.4 (C-7), 175.4 (C-4),
192.6 (CO) ppm. EI-MS: m/z (rel. int.)  590 (9) [M·], 500 (18),
499 (14), 132 (9), 131 (9), 117 (5), 103 (7), 91 (100), 77 (6), 65 (10).
C40H30O5 (590.7): calcd. C 81.34, H 5.12; found C 81.01, H. 5.09.
7,4-Dibenzyloxy-3-(4-benzyloxycinnamoyl)-2-styrylchromone (4d):
Yellowish oil. 1H NMR: δ  5.09 and 5.09 (2s, 4 H, 4,4-
OCH2C6H5), 5.30 (s, 2 H, 5-OCH2C6H5), 6.85 (s, 1 H, 8-H), 6.90
(d, J  15.8 Hz, 1 H, α-H), 6.96 (d, J  8.8 Hz, 2 H, 3,5-H),
6.97 (d, J  8.7 Hz, 2 H, 3,5-H), 7.11 (d, J  16.0 Hz, 1 H, α-
H), 7.13 (d, J  8.0 Hz, 1 H, 6-H), 7.287.44 (m, 13 H, 3,4,5-H
of 7-OCH2C6H5 and 2,3,4,5,6-H of 4,4-OCH2C6H5), 7.51 (d, J
8.7 Hz, 2 H, 2,6-H), 7.53 (t, J  8.0 Hz, 1 H, 5-H), 7.55 (d, J 
8.8 Hz, 2 H, 2,6-H), 7.59 (d, J  7.2 Hz, 2 H, 2,6-H of 7-
OCH2C6H5), 7.64 (d, J  16.0 Hz, 1 H, β-H), 7.64 (d, J 
15.8 Hz, 1 H, β-H) ppm. 13C NMR: δ  70.0 and 70.1 (4,4-
OCH2C6H5), 70.6 (7-OCH2C6H5), 101.2 (C-8), 114.9 (C-6), 115.2
(C-3,5), 115.3 (C-3,5), 115.9 (C-α), 117.9 (C-10), 121.7 (C-3),
125.7 (C-α), 127.5 (C-5), 127.6, 128.1, 128.1, 128.1, 128.4, 128.6,
and 128.8 (C-1,1 and C-2,3,4,5,6 of 4,4-OCH2C6H5), 129.8 (C-
2,6), 130.5 (C-2,6), 135.6 (C-1 of 7-OCH2C6H5), 136.4 (C-1 of
4,4-OCH2C6H5), 138.6 (C-β), 144.1 (C-β), 156.9 (C-9), 160.5 (C-
4), 160.9 (C-4), 161.3 (C-2), 163.5 (C-7), 175.8 (C-4), 192.2 (C
O) ppm. MS-FAB(): m/z (rel. int.)  697 (30) [M  H], 696
(12), 605 (4), 461 (5), 397 (8), 307 (28), 289 (3), 237 (8), 154 (88),
137 (57), 136 (56), 120 (10), 107 (18), 91 (100), 77 (16). FAB-HRMS
(C47H37O6, [M  H]): calcd. 697.2512, found 697.2505.
5,4-Dibenzyloxy-3-(4-benzyloxycinnamoyl)-2-styrylchromone (4e):
M.p. 192194 °C (recrystallised from ethanol). 1H NMR: δ  5.09
(s, 4 H, 4,4-OCH2C6H5), 5.29 (s, 2 H, 5-OCH2C6H5), 6.86 (d,
J  8.0 Hz, 1 H, 6-H), 6.90 (d, J  15.9 Hz, 1 H, α-H), 6.94 (d,
J  8.7 Hz, 2 H, 3,5-H), 6.97 (d, J  8.7 Hz, 2 H, 3,5-H), 7.11
(d, J  15.9 Hz, 1 H, α-H), 7.12 (d, J  8.0 Hz, 1 H, 8-H),
7.287.44 (m, 13 H, 3,4,5-H of 5-OCH2C6H5 and 2,3,4,5,6-H of
4,4-OCH2C6H5), 7.50 (d, J  8.8 Hz, 2 H, 2,6-H), 7.54 (t, J 
8.0 Hz, 1 H, 7-H), 7.55 (d, J  8.8 Hz, 2 H, 2,6-H), 7.58 (d,
J  8.2 Hz, 2 H, 2,6-H of 5-OCH2C6H5), 7.64 (d, J  15.9 Hz, 2
H, β,β-H) ppm. 13C NMR: δ  70.1 (4,4-OCH2C6H5), 70.9 (5-
OCH2C6H5), 108.6 (C-6), 110.1 (C-8), 114.9 (C-10), 115.1 (C-
3,5), 115.2 (C-3,5), 115.5 (C-α), 123.2 (C-3), 125.7 (C-α),
126.7 (C-2,6 of 5-OCH2C6H5), 127.5 (C-2,6 of 4,4-OCH2C6H5),
127.6, 128.0, 128.1, and 128.6 (C-1,1 and C-3,4,5 of 5,4,4-
OCH2C6H5), 129.7 (C-2,6), 130.6 (C-2,6), 134.0 (C-7), 136.4
(C-1 of 5,4,4-OCH2C6H5), 138.3 (C-β), 144.2 (C-β), 157.3 (C-
9), 158.8 (C-5), 159.2 (C-2), 160.4 (C-4), 160.8 (C-4), 176.1 (C-
4), 192.5 (CO) ppm. MS-FAB: m/z (rel. int.)  697 (25) [M 
H], 696 (10), 605 (3), 460 (6), 397 (6), 307 (38), 289 (16), 212 (8),
180 (7), 154 (100), 137 (63), 136 (62), 120 (11), 107 (19), 91 (59),
77 (16), 65 (87), 51 (7). FAB-HRMS (C47H37O6, [M  H]): calcd.
697.2512, found 697.2519.
5,7,4-Tribenzyloxy-3-(4-benzyloxycinnamoyl)-2-styrylchromone
(4f): Yellowish oil. 1H NMR: δ  5.08 (s, 4 H, 4,4-OCH2C6H5),
5.14 (s, 2 H, 7-OCH2C6H5), 5.21 (s, 2 H, 5-OCH2C6H5), 6.49 (d,
J  2.1 Hz, 1 H, 6-H), 6.66 (d, J  2.1 Hz, 1 H, 8-H), 6.87 (d, J 
15.9 Hz, 1 H, α-H), 6.95 (d, J  8.8 Hz, 2 H, 3,5-H), 6.95 (d,
J  8.7 Hz, 2 H, 3,5-H), 7.11 (d, J  16.1 Hz, 1 H, α-H),
7.277.52 (m, 24 H, 2,6,2,6-H and 2,3,4,5,6-H of 5,7,4,4-
OCH2C6H5), 7.58 (d, J  16.1 Hz, 1 H, β-H), 7.63 (d, J 
15.9 Hz, 1 H, β-H) ppm. 13C NMR: δ  70.1 (4,4-OCH2C6H5),
70.6 (7-OCH2C6H5), 70.8 (5-OCH2C6H5), 94.0 (C-8), 98.4 (C-6),
109.6 (C-10), 115.1 (C-3,5), 115.2 (C-3,5), 115.6 (C-α), 123.2
(C-3), 125.9 (C-α), 126.6, 127.5, 127.7, 127.9, 128.1, 128.5, 128.6,
and 128.8 (C-1, C-1 and C-2,3,4,5,6 of 5,7,4,4-OCH2C6H5),
129.6 (C-2,6), 130.6 (C-2,6), 135.6 (C-1 of 7-OCH2C6H5),
136.2 (C-1 of 5-OCH2C6H5), 136.4 (C-1 of 4,4-OCH2C6H5),
137.8 (C-β), 144.1 (C-β), 158.8 (C-2,9), 160.0 (C-5), 160.3 (C-4),
160.8 (C-4), 163.3 (C-7), 175.4 (C-4), 192.7 (CO) ppm. MS-
FAB: m/z (rel. int.)  803 (10) [M  H], 802 (5), 711 (5), 503
(6), 237 (10), 154 (8), 136 (12), 107 (6), 91 (100), 77 (8), 73 (19).
FAB-HRMS (C54H43O7, [M  H]): calcd. 803.2931, found
803.2941.
Synthesis of Hydroxy-2-styrylchromones 5ai: The appropriate
benzyloxy-2-styrylchromone 3ai (2.5 mmol) was added to a solu-
tion of hydrogen bromide in acetic acid (33 %, 50 mL). The mixture
was refluxed for 12 hours. The solution was carefully poured into
ice and water, and the solid so-obtained was removed by filtration.
The solid was dissolved in ethyl acetate (20 mL) and washed with
water several times. After evaporation of the solvent, the residue
was purified by silica gel column chromatography using a mixture
of chloroform:acetone (8:2) as eluent. The solvent was evaporated
to dryness in each case, and the residue was precipitated from etha-
nol with water to give the expected products 5ai.
7-Hydroxy-2-styrylchromone (5a): Yield 58.0 % (383 mg). M.p.
195197 °C (recrystallised from a mixture of ethanol and water).
1H NMR ([D6]DMSO): δ  6.34 (s, 1 H, 3-H), 6.90 (dd, J  8.7,
2.2 Hz, 1 H, 6-H), 6.95 (d, J  2.2 Hz, 1 H, 8-H), 7.18 (d, J 
16.2 Hz, 1 H, α-H), 7.407.48 (m, 3 H, 3,4,5-H), 7.65 (d, J 
16.2 Hz, 1 H, β-H), 7.72 (d, J  6.9 Hz, 2 H, 2,6-H), 7.85 (d,
J  8.7 Hz, 1 H, 5-H), 10.84 (br. s, 1 H, 7-OH) ppm. 13C NMR
([D6]DMSO): δ  102.4 (C-8), 110.0 (C-3), 114.8 (C-6), 116.4 (C-
10), 120.7 (C-α), 126.6 (C-5), 127.7 (C-2,6), 129.0 (C-3,5), 129.7
(C-4), 135.1 (C-1), 135.7 (C-β), 157.3 (C-9), 161.0 (C-2), 162.8 (C-
7), 176.4 (C-4) ppm. EI-MS: m/z (rel. int.)  264 (83) [M·], 263
(100), 247 (43), 235 (13), 207 (6), 178 (6), 155 (12), 137 (32), 128
(47), 118 (9), 108 (12), 102 (12), 91 (6), 77 (9), 63 (7), 51 (11).
C17H12O3 (264.3): calcd. C 77.26, H 4.58; found C 76.83, H 5.02.
5-Hydroxy-2-styrylchromone (5b): Yield 51.1 % (337 mg). M.p.
152154 °C (recrystallised from a mixture of ethanol and water).
1H NMR: δ  6.24 (s, 1 H, 3-H), 6.75 (d, J  16.0 Hz, 1 H, α-H),
6.79 (dd, J  8.3, 0.8 Hz, 1 H, 6-H), 6.96 (dd, J  8.3, 0.8 Hz, 1
H, 8-H), 7.42 (m, 3 H, 3,4,5-H), 7.52 (t, J  8.3 Hz, 1 H, 7-H),
7.58 (m, 2 H, 2,6-H), 7.61 (d, J  16.0 Hz, 1 H, β-H), 12.60 (s, 1
H, 5-OH) ppm. 13C NMR: δ  106.8 (C-8), 109.0 (C-3), 110.9 (C-
10), 111.3 (C-6), 119.5 (C-α), 127.8 (C-2,6), 129.0 (C-3,5), 130.2
(C-4), 134.7 (C-1), 135.3 (C-7), 138.0 (C-β), 156.2 (C-9), 160.8 (C-
5), 162.8 (C-2), 183.6 (C-4) ppm. EI-MS: m/z (rel. int.)  264 (100)
[M·], 263 (84), 246 (32), 235 (6), 218 (8), 189 (7), 155 (7), 136 (22),
128 (35), 127 (11), 108 (24), 102 (8), 91 (6), 77 (8), 51 (7). C17H12O3
(264.3): calcd. C 77.26, H 4.58; found C 77.13, H 4.57.
5,7-Dihydroxy-2-styrylchromone (5c): Yield 48.0 % (336 mg). M.p.
246248 °C (recrystallised from a mixture of ethanol and water).
1H NMR ([D6]DMSO): δ  6.19 (d, J  2.1 Hz, 1 H, 6-H), 6.39
(s, 1 H, 3-H), 6.47 (d, J  2.1 Hz, 1 H, 8-H), 7.18 (d, J  16.2 Hz,
1 H, α-H), 7.417.49 (m, 3 H, 3,4,5-H), 7.67 (d, J  16.2 Hz, 1
H, β-H), 7.73 (dd, J  7.3, 1.6 Hz, 2 H, 2,6-H), 10.9 (br. s, 1 H,
7-OH), 12.86 (br. s, 1 H, 5-OH) ppm. 13C NMR ([D6]DMSO): δ 
94.0 (C-8), 98.8 (C-6), 104.1 (C-10), 108.3 (C-3), 120.1 (C-α), 127.9
(C-2,6), 129.1 (C-3,5), 130.0 (C-4), 134.9 (C-1), 136.9 (C-β),
157.3 (C-9), 161.6 (C-5), 162.3 (C-2), 164.4 (C-7), 181.7 (C-4) ppm.
EI-MS: m/z (rel. int.)  280 (100) (M·), 279 (89), 262 (20), 251
(8), 234 (6), 165 (5), 153 (19), 128 (38), 124 (18), 102 (8), 77 (9), 69
(15), 63 (4), 51 (8). C17H12O4 (280.3): calcd. C 72.85, H 4.32; found
C 72.84, H 4.10.
7,4-Dihydroxy-2-styrylchromone (5d): Yield 86.0 % (602 mg). M.p.
306307 °C (recrystallised from a mixture of ethanol and water).
1H NMR ([D6]DMSO): δ  6.25 (s, 1 H, 3-H), 6.83 (d, J  8.6 Hz,
2 H, 3,5-H), 6.88 (dd, J  8.7, 2.2 Hz, 1 H, 6-H), 6.92 (d, J 
2.2 Hz, 1 H, 8-H), 6.92 (d, J  16.2 Hz, 1 H, α-H), 7.55 (d, J 
16.2 Hz, 1 H, β-H), 7.56 (d, J  8.6 Hz, 2 H, 2,6-H), 7.83 (d, J 
8.7 Hz, 1 H, 5-H), 9.98 (br. s, 1 H, 4-OH), 10.78 (br. s, 1 H, 7-
OH) ppm. 13C NMR ([D6]DMSO): δ  102.4 (C-8), 108.8 (C-3),
114.6 (C-6), 115.9 (C-3,5), 116.4 (C-10), 117.1 (C-α), 126.3 (C-
1), 126.6 (C-5), 129.7 (C-2,6), 136.1 (C-β), 157.3 (C-9), 159.2 (C-
4), 161.8 (C-2), 162.7 (C-7), 176.3 (C-4) ppm. EI-MS: m/z (rel.
int.)  280 (100) [M·], 279 (97), 263 (45), 251 (15), 234 (5), 223
(5), 171 (7), 144 (25), 137 (38), 126 (11), 115 (38), 108 (10), 89 (7),
84 (34), 66 (40), 63 (8), 52 (8), 51 (8). C17H12O4 (280.3): calcd. C
72.85, H 4.32; found C 72.54, H 4.42.
5,4-Dihydroxy-2-styrylchromone (5e): Yield 63.0 % (441 mg). M.p.
278280 °C (recrystallised from a mixture of ethanol and water).
1H NMR ([D6]DMSO): δ  6.44 (s, 1 H, 3-H), 6.78 (d, J  8.2 Hz,
1 H, 6-H), 6.84 (d, J  8.6 Hz, 2 H, 3,5-H), 6.99 (d, J  16.1 Hz,
1 H, α-H), 7.11 (dd, J  8.2, 0.7 Hz, 1 H, 8-H), 7.59 (d, J  8.6 Hz,
2 H, 2,6-H), 7.65 (t, J  8.2 Hz, 1 H, 7-H), 7.66 (d, J  16.1 Hz,
1 H, β-H), 10.10 (br. s, 1 H, 4-OH), 12.79 (s, 1 H, 5-OH) ppm.
13C NMR ([D6]DMSO): δ  107.2 (C-8), 107.4 (C-3), 110.2 (C-
10), 110.8 (C-6), 116.0 (C-3,5), 116.2 (C-α), 125.9 (C-1), 130.0
(C-2,6), 135.8 (C-7), 138.3 (C-β), 155.7 (C-9), 159.7 (C- 4), 160.0
(C-5), 164.1 (C-2), 182.9 (C-4) ppm. EI-MS: m/z (rel. int.)  280
(100) [M·], 279 (81), 262 (36), 251 (11), 234 (7), 205 (6), 171 (6),
144 (41), 137 (33), 126 (7), 115 (36), 108 (19), 89 (8), 63 (8), 52 (8),
51 (8). C17H12O4 (280.3): calcd. C 72.85, H 4.32; found C 72.68,
H 4.35.
5,7,4-Trihydroxy-2-styrylchromone (5f): Yield 50.0 % (370 mg).
M.p. 225226 °C (recrystallised from a mixture of ethanol and
water). 1H NMR [(CD3)2CO]: δ  6.22 (s, 1 H, 3-H), 6.24 (s, 1 H,
6-H), 6.49 (s, 1 H, 8-H), 6.92 (d, J  8.8 Hz, 2 H, 3,5-H), 6.92
(d, J  15.9 Hz, 1 H, α-H), 7.60 (d, J  8.8 Hz, 2 H, 2,6-H), 7.64
(d, J  15.9 Hz, 1 H, β-H), 13.01 (s, 1 H, 5-OH) ppm. 13C NMR
[(CD3)2CO]: δ  93.3 (C-8), 98.2 (C-6), 104.2 (C-10), 106.8 (C-3),
115.4 (C-3,5), 116.2 (C-α), 126.4 (C-1), 129.3 (C-2,6), 136.8 (C-
β), 157.3 (C-9), 159.0 (C-4), 162.1 (C-5), 162.8 (C-2), 163.6 (C-7),
181.7 (C-4) ppm. EI-MS: m/z (rel. int.)  296 (100) [M·], 295 (98),
279 (32), 267 (15), 250 (7), 241 (6), 213 (8), 171 (9), 165 (17); 153
(44), 144 (37), 134 (18), 123 (12), 115 (39), 96 (7), 91 (10), 78 (7),
69 (21), 55 (6), 51 (5). C17H12O5 (296.3): calcd. C 68.92, H 4.08;
found C 68.98, H 4.05.
7,3,4-Trihydroxy-2-styrylchromone (5g): Yield 80.0 % (592 mg).
M.p. 310311 °C (recrystallised from a mixture of ethanol and
water). 1H NMR ([D6]DMSO): δ  6.27 (s, 1 H, 3-H), 6.79 (d, J 
8.2 Hz, 1 H, 5-H), 6.82 (d, J  16.1 Hz, 1 H, α-H), 6.86 (dd, J 
8.7, 2.2 Hz, 1 H, 6-H), 6.93 (d, J  2.2 Hz, 1 H, 8-H), 7.02 (dd,
J  8.2, 1.8 Hz, 1 H, 6-H), 7.10 (d, J  1.8 Hz, 1 H, 2-H), 7.47
(d, J  16.1 Hz, 1 H, β-H), 7.83 (d, J  8.7 Hz, 1 H, 5-H), 10.8
(br. s, 1 H, 7-OH) ppm. 13C NMR ([D6]DMSO): δ  102.4 (C-8),
108.8 (C-3), 114.3 (C-2), 114.6 (C-6), 115.8 (C-5), 116.4 (C-10),
116.9 (C-α), 120.8 (C-6), 126.5 (C-5), 126.7 (C-1), 136.4 (C-β),
145.7 (C-3), 147.8 (C-4), 157.3 (C-9), 161.8 (C-2), 162.6 (C-7),
176.3 (C-4) ppm. EI-MS: m/z (rel. int.)  296 (100) [M·], 295 (58),
279 (25), 267 (9), 249 (9), 221 (8), 187 (9), 176 (17), 160 (18), 137
(58), 114 (12), 84 (32), 66 (38), 63 (8), 52 (6), 51 (8). C17H12O5
(296.3): calcd. C 68.92, H 4.08; found C 68.99, H 4.23.
5,3,4-Trihydroxy-2-styrylchromone (5h): Yield 55.0 % (407 mg).
M.p. 275276 °C (recrystallised from a mixture of ethanol and
water). 1H NMR ([D6]DMSO): δ  6.47 (s, 1 H, 3-H), 6.78 (d, J 
8.2 Hz, 1 H, 6-H), 6.81 (d, J  8.1 Hz, 1 H, 5-H), 6.88 (d, J 
16.1 Hz, 1 H, α-H), 7.02 (br. d, J  8.1 Hz, 1 H, 6-H), 7.12 (d,
J  8.2 Hz, 1 H, 8-H), 7.13 (d, J  2.7 Hz, 1 H, 2-H), 7.59 (d,
J  16.1 Hz, 1 H, β-H), 7.64 (t, J  8.2 Hz, 1 H, 7-H), 9.23 (br. s,
1 H, 3-OH), 9.69 (br. s, 1 H, 4-OH), 12.80 (s, 1 H, 5-OH) ppm.
13C NMR ([D6]DMSO): δ  107.2 (C-8), 107.4 (C-3), 110.2 (C-
10), 110.8 (C-6), 114.5 (C-2), 115.9 (C-5), 116.1 (C-α), 121.3 (C-
6), 126.4 (C-1), 135.7 (C-7), 138.7 (C-β), 145.7 (C-3), 148.4 (C-
4), 155.7 (C-9), 160.0 (C-5), 164.1 (C- 2), 182.9 (C-4) ppm. EI-MS:
m/z (rel. int.)  296 (100) [M·], 295 (63), 279 (25), 267 (7), 249
(11), 221 (8), 186 (7), 176 (8), 160 (40), 137 (65), 114 (20), 108 (17),
88 (7), 77 (9), 63 (8), 52 (9), 51 (10). C17H12O5 (296.3): calcd. C
68.92, H 4.08; found C 68.86, H 4.30.
5,7,3,4-Tetrahydroxy-2-styrylchromone (5i): Yield 27.1 %
(211 mg). M.p. 304306 °C (recrystallised from a mixture of etha-
nol and water). 1H NMR ([D6]DMSO): δ  6.17 (d, J  2.0 Hz,
1 H, 6-H), 6.32 (s, 1 H, 3-H), 6.45 (d, J  2.0 Hz, 1 H, 8-H), 6.79
(d, J  8.2 Hz, 1 H, 5-H), 6.82 (d, J  16.0 Hz, 1 H, α-H), 7.02
(dd, J  8.2, 2.0 Hz, 1 H, 6-H), 7.10 (d, J  2.0 Hz, 1 H, 2-H),
7.51 (d, J  16.0 Hz, 1 H, β-H), 9.20 (br. s, 1 H, 3-OH), 9.64 (br.
s, 1 H, 4-OH), 10.85 (br. s, 1 H, 7-OH), 12.96 (br. s, 1 H, 5-OH)
ppm. 13C NMR ([D6]DMSO): δ  93.9 (C-8), 98.7 (C-6), 104.0 (C-
10), 107.0 (C-3), 114.4 (C-2), 115.9 (C-5), 116.2 (C-α), 121.1 (C-
6), 126.5 (C-1), 137.7 (C-β), 145.7 (C-3), 148.1 (C-4), 157.2 (C-
9), 161.5 (C-5), 163.2 (C-2), 164.2 (C-7), 181.7 (C-4) ppm. EI-MS:
m/z (rel. int.)  312 (13) [M·], 311 (9), 295 (2), 281 (3), 191 (10),
160 (4), 153 (8), 146 (35), 122 (3), 91 (4), 78 (85), 63 (100), 51 (2).
C17H12O6 (312.3): calcd. C 65.39, H 3.87; found C 65.53, H 4.07.
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